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Abstract 
The weak routine immunization activities in Nigeria have led to an upsurge of vaccine preventable diseases 
such as poliomyelitis in the northern parts of the country. This made the federal government to intensify 
efforts to improve routine immunization activities with various intervention programmes over the years. 
This commitment of the federal government towards improving routine immunization as a way to promote 
infant and child survival led to the partnership between the UK Department for International Development 
(DFID) to support the launching of Partnership for Reviving Routine Immunization in Northern Nigeria 
(PRRINN) programme in 2006. The programme, implemented in the northern states of Jigawa, Katsina, 
Yobe, and Zamfara was intended to augment other federal government immunization intervention efforts in 
improving routine immunizations services. After five years of programme implementation, assessment of 
the effectiveness of PRRINN had not be undertaken using a survey based immunization coverage to 
establish how well the primary objectives of the programme are being met in terms of improving routine 
immunization.  
 
This study was designed to evaluate the performance of the PRRINN programme in improving routine 
immunization coverage in Jigawa State using coverage data from the National Immunization Coverage 
Survey (NICS) of 2010.  
 
A quasi-experimental ‘before and after’ study design was used to evaluate the effectiveness of PPRINN in 
Jigawa State in respect to its primary objective of improving immunization coverage in the State. The study 
used secondary data sets from the National Immunization Coverage Survey (NICS) of 2006 and 2010, and 
routine immunization data collected at selected primary health facilities in the State. Key Informants’ 
Interviews (KII) were also conducted to complement the information gathered from the surveys and record 
reviews. The current status of immunization coverage for Jigawa State was determined and compared with 
the immunization coverage of the State in 2006. The immunization access and continuity was determined 
using the drop-out rates of DPT antigen.  Status of the routine immunization in the health facilities was 
determined. 
 
The data extracted from the NICS of 2006 and 2010 were analyzed using the customized coverage survey 
and analysis software (COSAS) and EpiInfo analysis software. COSAS was employed for analyzing the data 
on infant immunization and a statistical analysis programme was developed in FOXPRO to analyze the TT 
immunization in women. The standard report by COSAS provided an automatic standard analysis that 
generated the main indicators for infant immunization: coverage summary tables for crude and valid 
coverage by doses of each antigen (BCG, OPV, DPT and Measles) and also for full immunization. Results 
were disaggregated into ‘card only’ and ‘card plus history’. The FOXPRO generated the indicators for TT 
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immunization: mother protection, child protection, TT immunization service utilization, TT immunization 
follow-up (Drop-out rates), missed opportunities in TT immunization and card retention. Comparative 
analysis using the absolute differences in coverage rates and  paired samples  t-test analysis was done to 
compare immunization data from NICS and health facilities before and after the commencement of  
PRRINN activities in Jigawa State in order to determine the improvement or otherwise of routine 
immunization performance in the State. 
 
Current immunization coverage status for Jigawa State was ascertained and compared with immunization 
coverage for 2006 which is taken as baseline before the commencement of PRRINN. The drop-out rates was 
also determined.  
 
BCG immunization which is used to measure contact to immunization delivery system was 92.9% for 2010, 
it went up by about 61.6% over the four year period during the implementation of the PRRINN and 
immunization partners programme in the State.  DPT 3 (88.7% for 2010) used to measure the strength of the 
immunization programme increased by 59.8% over the 2006 coverage. OPV3 coverage rate reported for 
2010 in Jigawa State which is 88.1% for all children, gave almost 43.3%  increment in the coverage over the 
four year period. It shows an improvement in the ability of the immunization service delivery system to give 
valid doses of vaccines to infants. Measles vaccine, used as an indicator to assess the ability of the delivery 
system to reach children before their first birthday and the last antigen to be given to a child showed that 
85% of children were reached before their first birthday in the State. Hepatitis B3 Vaccine Coverage was 
encouraging at 87.5% which indicates that over 80% of the children were immunized with the vaccine. The 
mother and child protection against tetanus toxoid measured by administration of at least two doses of TT 
was also evidently increased from 9% coverage in 2006 to over 64% coverage in 2010, an over 55% 
increment over the four year period. This is an indication of an improved immunization systeme and 
increased demand for the immunization services. 
 
This evaluation has revealed that there is an increase in immunization coverage in Jigawa State. The paired 
samples t-test analysis conducted showed a significance value of .000 which indicates that there is 
significance difference between the means of the coverage rates for 2006 and 2010. Hence, a conclusion that 
PRRINN and other partners immunization programmes was responsible for the increase in immunization 
coverage in the State. It shows that the concerted effort of the immunization partners in the State in 
strengthening the PHC system and improving routine immunization in the State has been successful in 
respect to access to immunization services and reduction of immunization drop-out rates.  
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Although the study started with the intention of measuring the performance of routine immunization in 
Jigawa State on the backdrop of the involvement of PRRINN, it can only be said that the improvements 
noticed in routine immunization in the State reflects the collaborative efforts of all partners (State Ministry 
of Health, Gunduma Health Board, World Health Organization, United Nations Children Fund, Partnership 
for Transforming Health Systems and PRRINN). Hence, contribution rather than exclusive attribution was 
what the study deduced for the role PRRINN played in reviving routine immunization in Jigawa State.  
 
The significance of this study is shown in using survey based data to measure performance and effectiveness 
of intervention programmes targeted at improving immunization activities 
 
Some recommendations that arose from this study include: 
 The State should commission more health facility and community based surveys to ascertain the 
State of routine immunization in the State in order to monitor actual progress 
 The Department of policy, planning and resource mobilization under the State Ministry of Health 
should ensure prompt approval for research studies in the State 
 The Jigawa State Ministry of Health under the auspices of the State government and partnership it 
has enjoyed must ensure continuity of the routine immunization revitalization programme and 
sustained the gains of the programmes 
 The State government should be prepared to take over full responsibility for most of the partners 
funded activities under immunization should the tenure of the partners expires in the State. 
 The other neighboring States should emulate Jigawa State model by implementing similar 
programmes to improve routine immunization in their States 
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Definitions 
 
Child/Childhood/Infant: Child is generally a human between the stages of birth and puberty. Childhood is 
the period covering the span between births and puberty. However, for immunization purposes a ‘child’ is 
defined as a human between the age of 11 to 59 months (1 to 5 years of age) while infants is a child aged 0 -
11 months.  
 
Crude Coverage: Crude coverage as immunization given, evidences by card where applicable or by history 
from mothers/guardians.  
 
Drop-out rates: Drop-out rates (between the first and last doses of a vaccine) are used to measure program 
continuity: drop-out rates between DPT 1 and DPT 3 are the best indicator of program continuity and 
follow-up of children in immunization.  
 
Fully Immunized Child (FIC): This is a child who has received doses of the ‘standard six’ antigens – 
BCG, diphtheria- pertussis-tetanus (DPT) (3 doses), polio (3 doses), and measles vaccines.  However in 
Nigeria, FIC also captures the additional indicators for Yellow Fever and hepatitis B vaccines. 
 
Fully Immunized Children (FIC) is an indicator which measures the number of children who have received 
the complete dosage of the following four antigens: BCG, 3 doses of DPT, 3 doses of Polio and Measles. 
 
OPV 3: is the third dose of the polio vaccine expected to be given to a child at 14 weeks according to the 
national immunization schedule 
 
Valid Coverage: this is the immunization given as evidenced by card. The validity is based on the presence 
of a card with a date when the vaccine was given. 
 
Vaccine Preventable Diseases (VPD): this is an infectious disease for which an effective preventive 
vaccine exists. Some of the VPD include anthrax, cervical cancer, diphtheria, hepatitis A & B, haemophilus 
influenza type B (Hib), human papillomavirus (HPV), influenza (flu), measles, meningococcal, mumps, 
pertusis, pneumococcal, polio e.t.c. 
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CHAPTER ONE 
 
1. Introduction 
 
1.1 Background 
In Nigeria, it is estimated that one child out of five dies before its fifth birthday of vaccine-preventable 
diseases (VPDs); this accounted for about 872,000 (22% of) childhood deaths in 2002
1
. The childhood 
mortality rate (CMR) was 97 per 1,000 live births in 2003 and 88 in 2008
2
. This follows the global trend 
which recorded a fall from 12.4 million in 1990 to about 8.1 million in 2009
3
. It is disturbing to note that just 
three countries accounted for 40% of the 8.1million global child deaths. These countries include Nigeria 
accounting for about 10% of global deaths second to India which accounted for 21.1% and Democratic 
Republic of Congo (6.4%). 
 
Immunization has been accepted worldwide as the proving tool for the control and prevention of life 
threatening infectious diseases, especially VPD in children and this holds true in the developing countries. 
Immunization has been proven to be the most cost-effective and equitable intervention strategies in primary 
healthcare delivery and is estimated to avert between 2 and 3 million deaths each year
4,5
. 
 
Immunization activities started in Nigeria in 1956 prior to the small pox eradication campaign. However, the 
Expanded Programme on Immunization (EPI) routine immunization (RI) against Diphtheria, Pertusis, 
Tetanus (DPT), measles, poliomyelitis and tuberculosis began in Nigeria in 1979 and the coverage increased 
steadily until 1990. The national BCG coverage during the period (1979 – 1990) rose steadily to reach 80% 
and 48% for measles.  However in the 1990s the coverage started reducing alarmingly that BCG coverage 
went down to 34% and measles to 30% 
6
. Though there was significant variation in the immunization 
coverage between the States and Federal Capital Territory during this period as detailed in the regional 
coverage rates in Nigeria Demographic and Health Survey of 1990 (see Table 1)
7
.  The decline in 
immunization coverage has been attributed to weak RI services due to inadequate financial planning and 
funding; stock-outs of immunization consumables; lack of government commitment in human resources 
development and poor immunization uptake among other challenges. 
 
Prior to the 1990s, the coverage of RI services was reportedly as high as 81.5% of newborns
8
. This good 
performance was not sustained in the years that followed as the introduction of National Programme on 
Immunization (NPI) in 1996 which replaced the EPI and mainly focused on polio eradication weakened the 
routine services in the country
1
. For example the nurses carrying out Supplementary Immunization 
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Activities (SIA), National Immunization Days (NIDs) and Immunization Plus Days (IPDs) were not 
available at the health centers and clinics to provide routine care as there were numerous campaigns targeted 
at eradicating polio every year
1
.  In terms of funds, routine immunization services did not receive the same 
attention that polio eradication programmes alone received. Recently the Bill Gates and Melinda Foundation 
declared that it had spent about $750m on polio eradication in Nigeria alone 
9
, while the 2011 total budget 
for National Primary Health Care Development Agency (NPHCDA) which oversees immunization services 
is N7.6 billion (approximately $48m)
10
.  The effect is that routine immunization services have consistently 
been weakened consistently since the 1990s
8
. 
 
Table 1: Percentage of children 12-23 months who had received specific vaccines by the time of the 
NDHS in 1990 
 Percentage of children who received:  
Background 
Characteristics 
BCG 
DPT Polio 
Measles 
Number 
of 
Children 
1 2 3+ 1 2 3+ 
Sex 
Male 
Female 
 
59.7 
61.7 
 
57.9 
60.5 
 
45.9 
47.6 
 
33.7 
32.9 
 
58.2 
61.1 
 
46.1 
47.9 
 
33.8 
32.9 
 
45.7 
46.4 
 
683 
697 
Region 
Northeast 
Northwest 
Southeast 
Southwest 
 
41.2 
52.6 
73.0 
81.6 
 
40.8 
51.7 
70.2 
79.8 
 
32.1 
35.1 
58.8 
66.5 
 
17.3 
18.7 
50.4 
51.0 
 
42.6 
51.7 
70.2 
79.8 
 
32.7 
35.1 
59.0 
66.5 
 
17.3 
18.7 
50.4 
51.3 
 
31.6 
39.7 
53.9 
64.0 
 
359 
373 
408 
240 
All children 60.7 59.2 46.8 33.3 59.7 47.0 33.4 46.0 1,380 
Extracted from Table 8.7 (vaccinations by background characteristics) of the Nigeria Demographic and 
Health Survey 1990. 
 
The Federal Government of Nigeria (FGN) acknowledged the importance of immunization as a means of 
controlling diseases, reducing deaths of infants/children and also as the most cost-effective health 
intervention
8, 11
. Therefore the UK Department for International Development (DFID) pledged resources to 
assist the Federal Ministry of Health to strengthen routine immunization services
8
. This partnership between 
DFID and the FGN finally led to the launch of the Partnership for Reviving Routine Immunization in 
Northern Nigeria (PRRINN) in 2006. PRRINN was designed to be implemented by a consortium of three 
organizations (Health Partners International, Save the Children UK, and GRID Consulting) and involves 
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working with stakeholders at all levels to ensure the improvement of immunization coverage in a sustainable 
manner, with routine immunization system strengthening as an entry point for strengthening the PHC 
system. Some of the project development objectives (PDO) are:  
 To improve the capacity of the States and LGAs to plan, implement and monitor routine 
immunization activities within the context of integrated primary healthcare. 
 Increased access to the uptake of immunization 
 Strengthened community ownership of immunization activities 
 
The programme was originally designed to run from 2006 to 2011 and focused on the northern States with 
the lowest immunization coverage rates. These are Jigawa, Katsina, Yobe, and Zamfara States which all 
have immunization coverage rates of less than 22% respectively
6
. The PRRINN programme was valued at 
£27.2 million. Following a favourable programme review and demonstration of value for money in 2010, the 
programme was extended till 2013. The reviews that have been done on the programme before now are 
summarized in table 2 below: 
 
Table 2: Previous reviews of PRRINN 
Type of Review Year Approach Output 
PRRINN Annual 
Review and MNCH 
Inception Review 
2009 
review of key documents and 
reports, interviews with 
PRRINN staff, key stakeholders 
at national, regional, State and 
LGA levels 
Report
12
 
PRRINN-MNCH 
Annual Review 
2010 
review of key documents and 
reports, interviews with 
PRRINN staff, key stakeholders 
at national, regional, State and 
LGA levels 
Report
13
 
Rapid Immunization 
Assessment 
2010 
the assessment of the cold chain, 
vaccine distribution systems and 
vaccine management at the State 
level  and in 4 LGAs and 8 
health facilities in each State 
Report
14
 
 
The infusion of additional financial resources from the Norwegian government in 2008 enabled the scope of 
the PRRINN programme to be expanded beyond improving immunization to improving the health of 
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mothers and children in the same States. Hence the new PRRINN-MNCH programme is two projects 
combined in one (DFID-funded PRRINN which began in 2006 and the Norwegian-funded Maternal, 
Neonatal and Child Health (MNCH) project which began in 2008).  
 
This study assessed the performance of routine immunization in Jigawa State to demonstrate the 
effectiveness of the DFID funded PRRINN component of PRRINN-MNCH activities in the State by 
comparing the immunization coverage and routine immunization data from the health facilities before the 
commencement of the programme to date.  
 
1.2 Research Setting 
Jigawa State is situated in the northwestern part of Nigeria. Kano State and Katsina State border Jigawa to 
the west, Bauchi State to the east and Yobe State to the northeast (Map 1). To the north, Jigawa shares an 
international border with Zinder Region in The Republic of Niger. 
  
The State has a total land area of approximately 22,410 square kilometers. Its topography is characterized by 
undulating land, with sand dunes of various sizes spanning several kilometers in parts of the State. The 
socio-cultural composition in Jigawa State could be described as homogeneous: Hausa/Fulani, who can be 
found in all parts of the State, mostly populates it. Kanuri are largely found in Hadejia Emirate, with some 
traces of Badawa mainly in its Northeastern parts. Even though each of the three dominant tribes continue to 
maintain their ethnic identity, a shared religion (Islam) and a long history of inter-marriages have continued 
to bind them together. 
 
Although population of the State is predominantly rural (90%), the distribution in terms of sex is almost 
equal between male (50.8%) and female (49.2%). This sex distribution pattern in the population is same 
across various constituencies in the State and between urban and rural areas. 
 
Jigawa State comprises 27 Local Government Area (LGAs), which are divided into 30 State Constituencies, 
grouped into 11 Federal Constituencies and 3 Senatorial Districts. These 27 LGAs are further subdivided 
into 77 Development Areas per law No. 5 of 2004 of the State House of Assembly. 
 
The State Ministry of Health (SMOH) comprises of five (5) departments and one parastatal – Gunduma 
Health System Board (GHSB). The primary and secondary healthcare systems are integrated and 
administered through 9 Gundumas (districts). As the supervising and coordinating authority on health 
matters within the State, the SMOH takes initiatives and ensures political support from the Government 
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towards achieving its laudable objectives.  
 
There are 13 Secondary Health Facilities (SHCs) managed by the SMOH and a tertiary health facility, 
Federal Medical Center (FMC) which is managed by Federal Ministry of Health (FMOH). There are 623 
primary healthcare facilities in the State; these are categorized into Health Posts (337), Health Clinics (134), 
Primary Healthcare Centers (61) and Dispensaries etc (91). 
 
Each of the Gundumas has three departments, headed by the Deputy Directors and the departments include 
the following: 
 Primary Health Care Department (reproductive health; nutritional promotion; immunization IMCI; 
disease, surveillance and control; health promotion and equity; monitoring, evaluation and 
operational research) 
 Hospital Department (clinical services and quality assurance) 
 Administration and Support Services Department (finance and accounts; drugs and logistics; human 
resources) 
The primary health care department is in charge of the immunization services within each district and due to 
integration of the health system under the GHS, immunization was provided at all level of care. The analysis 
of the findings from the Jigawa State listing survey revealed that a total of 4,906,029 people access health 
care services from the 623 primary health facilities across the 27 LGAs of jigawa State. It gives an average 
of one primary health facility servicing an estimated 7,875 people in 2011 
15
. 
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Map 1: Administrative Map of Nigeria showing Jigawa State (red ringed) 
 
 
Map 2: Administrative Map of Jigawa State showing the 27 LGAs 
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1.3 Problem Statement 
A major health system challenge in Jigawa State is the weak immunization service delivery with almost non 
existing routine services. Even with the focus on polio eradication programmes, and the reporting of high 
coverage after each round of immunization activities, the complete eradication of polio in northern Nigeria 
is still a challenge. It is believed that the upsurge of WPV-3 predominantly in the northern parts of the 
country is associated with poor routine immunization. Though it could be addressed through good quality 
immunization rounds, a sound routine immunization system could have handled the WPV3 and various 
VPD that we have as a problem in the country now (especially in the North).  A demographic and health 
survey in 2008 showed that States like Sokoto, Zamfara, Jigawa, Yobe and Borno have less than 10% of 
their infants fully immunized at the age of one
2
. Low routine immunization coverage has been linked to low 
proportion of infants of one year old fully immunized as demonstrated in the northern states of Sokoto, 
Zamfara, Jigawa, Yobe, Borno, Gombe, Bauchi, Kano, Kaduna and Kebbi. This is a pointer that routine 
immunization system is not operating well in this part of the country. 
 
So the initiative of PRRINN and other immunization intervention programmes to revive routine 
immunization activities is believed to be logical. After five years of programme implementation, there has 
been no substantive evaluation of the programme, except for the annual reviews (done twice so far) but 
which did not include survey based data and made cursory attempt to track performance of PRRINN in 
respect of immunization coverage. Hence, a thorough and systematic assessment of the performance of 
routine immunization in Jigawa State before and after PRRINN had not been conducted.  
 
1.4 Rationale for the study 
The assessment of routine immunization performance in Jigawa State based on the status of immunization 
coverage and routine immunization activities in the State will help in understanding if the public health 
programme activities being implemented in the State are achieving the objectives of improving routine 
immunization in the State.  
 
More so, the independent assessment of new public health intervention programmes like PRRINN is 
necessary to appraise the performance of the programme against key outcome indicators. Knowing the 
effectiveness of the PRRINN intervention programme will inform future actions; for example, if the 
assessment is positive, then the replication of the programme in other States will be evidenced-based. The 
assessment is also good for the monitoring and evaluation component of such programmes.  
 
This research study will provide assessment for the performance of routine immunization in the State since 
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the inception of the renewed efforts of the government to improve routine immunization and the creation of 
the PRRINN intervention programme in this setting. This is expected to contribute significantly to the 
general assessment of PRRINN efforts at improving routine immunization in Jigawa State. Comparing the 
current survey based immunization coverage of the State with the coverage figures from national survey 
based coverage in 2006 will reveal the status of routine immunization in the State. The analysis of the 
survey based data is expected to give an unbiased assessment of RI in Jigawa State.  
 
1.5 Aim of the Research Study 
The aim of this study was to evaluate the performance of the ‘Partnership for Reviving Routine 
Immunization in Northern Nigeria’ (PRRINN) in improving routine immunization coverage in Jigawa State. 
 
1.6 Objectives of the Research Study 
 To determine the current status of immunization coverage for Jigawa State, after five years of 
PRRINN programme implementation. 
 To measure and compare the drop-out between first and third dose of DPT, the proportion of full 
immunized children over the five year period, and determine the factors affecting immunization. 
 To ascertain the status of routine immunization in the primary health facilities spread across the 27 
LGAs of Jigawa State. 
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CHAPTER TWO 
 
2. Literature Review  
 
2.1 Immunization Services  
Routine immunization is the corner stone of public health intervention to VPDs, as it is the most cost-
effective clinical preventive service for children, saving both lives and money
16
. Immunization against 
VPDs has greatly improved globally. It was reported that the number of children immunized against VPDs 
has gone up from 20% in 1980 to about 80% in 1996
17
. It is further estimated that as many as 2.8 million 
child deaths have been prevented annually as a result of immunization for VPDs
18
. Studies by the World 
Health Organization (WHO) have shown that the number of children saved from death from VPDs has 
increased steadily over the years with figures of 800,000 lives saved in 1988
19
 and increasing to over 2 
million in 2006
16
.  
 
However the performance of immunization programmes in developing countries remains dismal. In 2006, 
over 1.4 million children died from VPDs. This observation is in tandem with the reported low 
immunization coverage in 2006: of 157 member countries of the WHO only 47 had DPT coverage greater 
than 80% in all districts or states
16
. Only five countries accounted for about half of global child deaths in 
2009, notably among these are India, Nigeria, and Democratic Republic of the Congo. This poor 
performance may be attributed to weak health systems characterized by inadequate funding, staffing and 
poor cold chain at health facilities and limited public awareness to mention but a few 
19
.  
 
In his review, Joanne Embree stated that “there is a need to assess the long term effect of the introduction of 
any immunisation programmes”20 and the sophisticated modelling techniques available have greatly 
improved our ability to predict the effect of public health interventions. It is imperative that the early or long 
term effect of the introduction of intervention programmes is assessed
20
. It is also important to actively 
monitor or evaluate the programmes in order to prepare for the eventualities of their effect on the health 
problems
20
.  
 
2.2  Immunization Schedule in Nigeria 
The immunization schedule for Nigeria and by extension for Jigawa State indicates that a child should be 
immunized against Tuberculosis and Hepatitis at birth with the BCG vaccine and first dosage of Hepatitis B 
Vaccine respectively. Thereafter, the child is administered DPT 1, OPV 1 and the second dose of the HB 
(HBV2) vaccines at 6 weeks; then the second dosage of both DPT (DPT 2) and OPV (OPV2) at 10 weeks. 
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The third dosage of DPT (DPT 3), OPV (OPV 3) and HB (HBV3) vaccines are given at 14 weeks while 
measles vaccine is given at 9 months.  
 
The schedule for Tetanus Toxoid in Nigeria indicates the second dosage of TT(TT2) vaccine should be 
given 4 weeks after the first contact with TT1 while TT3 should be given 6 months after TT2; TT4 given at 
least a year after TT3 or during subsequent pregnancy while TT5 is given at least a year after TT4 or during 
subsequent pregnancy 
21
. 
 
Data were therefore collected on the immunization indicators (antigens) as specified in the national 
immunization schedule above during immunization coverage survey and routinely at the health facilities. 
Infant immunization was reported in NICS 2006 under the following; as crude, valid and valid by 52 weeks 
of age. Each of these is reported under ‘card + history’ and ‘card only’.  However, the NICS 2010 reported 
the immunization coverage as crude coverage (‘card + history’ and ‘card only’) and valid coverage (‘card + 
history’ and ‘card only’) 21. 
 
Crude Coverage: this is immunization given, evidences by card where applicable or by history from 
mothers/guardians. There is no emphasis on timing and or time-interval as required by the schedule. This 
actually measures the ability of a delivery system in administering doses at the right time in line with the 
national immunization schedule.  
 
Valid Coverage: this is the immunization given as evidenced by card. The validity is based on the presence 
of a card with a date when the vaccine was given. This is immunization given at the specified minimum age 
and interval in line with the national schedule. Valid coverage can either be either valid immunization given 
under one year of age or valid immunization given beyond one year of age.  This indicator is used to 
measure the ability of a delivery system to reach children in their first year of age and also beyond the age of 
1 year and vaccinate them at appropriate dose interval. 
 
The following vaccine immunization coverage given in Nigeria are used as indices to measure immunization 
delivery system performance among other things: 
 
BCG 
BCG is the first vaccine to be given to an infant at birth if he/she is born in a health facility. This is an 
indicator used in measuring the access to immunization services because the vaccine is given to the infant at 
his/her first contact with the immunization system. 
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OPV 3 
OPV 3 is the third dose of the polio vaccine expected to be given to a child at 14 weeks according to the 
national immunization schedule. It is relevant to note that polio virus is still a huge challenge to the 
immunization service delivery system in Nigeria and it was pointed out in the NICS 2006 report
4
 that a 
sound routine immunization is key to eradicating polio scourge in the northern part of the country. It is an 
indicator also used to measure the ability of the immunization service delivery system to give valid doses of 
vaccines to infants. 
 
DPT 3 
DPT 3 is the third dose of the DPT vaccine expected to be given to a child at 14 weeks according to the 
national immunization schedule. It is a globally accepted indicator to assess immunization coverage trends. 
A child who was recorded as having been given DPT 3 is expected to have gone through the complete cycle 
of routine immunization and he/she is expected to have received the other vaccines (BCG, OPV 1 – 3 and 
DPT 1 – 3). In some instances, across the immunization offices in Nigeria, DPT 3 is usually used routinely 
to report FIC since the factual FIC coverage can only be gotten during surveys which are not done yearly.  
 
Measles 
In Nigeria, measles vaccine is given to a child at 9 months (39 weeks) according to the national 
immunization schedule. Measles vaccine which is administered as a single dose is the last antigen to be 
given to a child. It is used as an indicator to assess the ability of the delivery system to reach children before 
their first birthday. In some cases measles vaccine coverage sometimes is used to signify FIC in the absence 
of the survey generated FIC that considers all antigens. 
 
Drop-out rates 
Drop-out from DPT1 to DPT3: The proportion of the children who received DPT 1 but did not receive  
DPT3 vaccine. This proportion reflects the deliberate contact with the immunization services and the last 
dose in multi-dose vaccinations. The period between the first dose of DPT 1 and DPT 3 is when most of all 
immunization is given to the child, so this DPT1 to DPT3 drop-out rate is a good indicator to assess 
continuity and compliance of the population with the immunization programme. 
 
Drop-out from BCG to DPT3 measures the difference between the first opportunity with immunization 
services and the last dose in multi-dose vaccinations. 
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2.3 Evaluation Studies 
In an evaluation study used in assessing the efficacy of non modest non-financial incentives and non-
incentives in improving immunization rates in children aged 1-3 years, a clustered randomized controlled 
study design was used
22
. The study was conducted in the rural setting of Rajasthan, India and the design was 
based on randomizing 134 villages into one of three groups. These groups include: a once-monthly reliable  
immunization camp (intervention A; 30 villages); a once-monthly reliable immunization camp with small 
incentives (intervention B; 30 villages), or control (no intervention, 74 villages). The study investigated the 
impact of a reliable supply of free immunization services and non-financial incentives on the demand for 
immunization services. The non-financial incentives given to group B included lentils and metal plates for 
completed immunization.  The study showed that offering families small, non-financial incentives in 
addition to reliable services and education had large impacts on the uptake of immunization services in 
resource poor areas and are more cost effective than just improving supply. The study was conducted in 
areas where the initial immunization rates were extremely low as found in Jigawa State. The generalizability 
of the survey can be assured only in the rural areas of Jigawa State, as similar interventions in the urban 
areas may not give remarkable result. The cost of giving incentives in the present setting may not be feasible 
except there are funding partners for such intervention. The report also reported confounding factors of 
villagers who might have been motivated to attend the camp for other motives, such as to prevent the 
cancellation of the programme.  
 
In another evaluation study done in 2008 to assess the progress towards universal childhood immunization 
(UCI) and the impact of global initiatives, the researchers hinged their findings on the survey-based DPT3 
immunization coverage as against the countries official reports or WHO and UNICEF estimates
23
. The study 
sought to address the issue of over-reporting of childhood immunization coverage rates which may be 
encouraged by target-oriented and performance-oriented initiatives like Universal Childhood Immunization 
(UCI) campaign and Global Alliance on Vaccines and Immunization (GAVI). The researchers used all 
available data to systematically assess the survey-based trend in DPT3 crude coverage during 1986 to 2006; 
and checked if global health initiatives such as UCI and GAVI ISS, led to over-reporting of DPT3 coverage. 
DPT3 coverage was estimated by analyzing unit record data from surveys and reported coverage from 
administrative data based on health service provider registries. The researchers then used bidirectional 
distance-dependent regression to estimate trends in survey based coverage in 193 countries between 1986 to 
2006. They further investigate any association in the difference between countries’ official reports and 
survey based coverage using standard time-series cross-sectional analysis. 
 
The result of the systematic analysis in the study depicted that the crude coverage of DPT3 immunization 
based on surveys varied when compared to the level suggested by countries’ official reports or the WHO 
 
 
 
 
13 | P a g e  
 
and UNICEF estimates
23
. The improvement in immunization coverage as revealed by data from surveys is 
more gradual than suggested by the official or administrative reports. The evaluation study done to assess 
the progress towards UCI and the impact of global initiatives shows the efficacy of using survey based data 
in evaluating the immunization based intervention programmes or initiatives.  The researchers argued that 
“monitoring and evaluation systems need to be based on rigorous, empirical measurements that are robust to 
these effects”. The study design used appropriate statistical methods for the study and the researchers 
carefully controlled for the period they need to get backcasting or forecasting survey-based coverage using 
sensitivity analysis (multiple imputation).  
 
Another independent assessment done by researchers in 2006 to evaluate the effect of the GAVI on 
immunization coverage used the DPT 3 coverage. The researchers “examined the relation between DPT3 
coverage for GAVI recipient countries from 1995 to 2004 and immunization services support (ISS) and non-
ISS expenditure per surviving child, controlling for income per head and local political governance 
variable”. Two different dependent variables were used to study the relationship between DTP3 coverage for 
GAVI recipient countries from 1995 to 2004. The dependent variables used were DPT3 coverage reported 
by government and DPT3 coverage estimates from WHO/UNICEF reports. The study concluded that the 
effect of GAVI on DPT3 coverage depicted that GAVI has contributed to increase of DPT3 coverage in 
countries with baseline coverage of 65% or less
24
. It can be concluded from the study that similar GAVI 
interventions can only be effective with countries that have DPT3 coverage of less than 65% at baseline. The 
study did not specify the type of DPT3 coverage used for the study; it was not clear if the crude coverage 
(card plus maternal-self report) or card only was used.  
  
Within Nigeria, the EPI was evaluated in Port Harcourt, Rivers State
25
. For this evaluation, the 
immunization status of children 9 months to 3 years who attended the children’s outpatient clinic of the 
University Teaching Hospital, Port Harcourt was compared before the commencement of the EPI 
programmes and 18 months after the commencement. The study showed an increase in the percentage of 
fully immunized children from 5% to 43% over a two year period (1984 – 1986). The study also 
demonstrated that the proportion of children with no vaccination dropped from 56% to 19% over the same 
period and called for an intensification of the immunization campaign in order to achieve full immunization 
coverage of 80%
25
. 
 
The trend in the evaluation of immunization programmes has been to measure performance in terms of the 
coverage rate of antigens or coverage rate of all antigens as a whole (full immunization)
 16
. We could begin 
to question if the only way to measure effectiveness of the different routine immunization programmes 
should be based on coverage rate for the antigens or the eradication of the diseases which the vaccines are 
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targeted at. The argument here is that if these vaccines are truly potent and they possess the presumed 
potential ‘herd effect’, then the yardstick for measurement of RI intervention programme could ultimately be 
the disappearance of the VPDs. Though the scope of the present study is also to measure performance of 
PRRINN in Jigawa State in terms of coverage rate, subsequent assessment studies should be based on 
disease incidence.  
 
2.4 Study Designs for Evaluating Immunization Intervention Programmes 
In a review
16
 of studies that evaluated intervention programmes to improve RI programmes in developing 
countries, various strategies were identified as having been used in different settings. These include 
observational studies, quasi experimental before and after evaluation studies, and studies with comparison 
group
9
. 
 
Twenty five evaluation studies that were selected in the review were on programmes that have reported 
success in improving routine immunization programmes through community and facility based interventions 
over a period of 38 years
16
. No strategy could be adjudged to be the best as some of the strategies were 
applied in the setting with high baseline coverage while others were in settings with low baseline coverage 
16
. 
 
 
The review showed that of the 25 studies reviewed, 8 used the before and after study design to carry out the 
evaluation of the intervention programmes. The before and after study design was able to report change in 
coverage compared to the other designs where immunization coverage were not reported.  However, the 
review reported that the generalizability of the evaluation studies could not be determined as most of the 
studies failed to discuss the comparison of the findings with other similar studies
16
.  
 
2.5 Partnership for Reviving Routine Immunization in Northern Nigeria (PRRINN) Intervention 
Programme 
The programme Partnership for Reviving Routine Immunization in Northern Nigeria (PRRINN) was 
originally designed by FBA Health Systems Analyst in 2005 for the UK Department for International 
Development DFID
26
. The project is a partnership between the following agencies; Health Partners 
International, Save the Children - UK, GRID Consulting, Health Reform Foundation of Nigeria, John 
Hopkins University Center for Communications Programs and Institute of Development, Partnership for 
Transforming Health PATH and Transaid
26
.   
 
In view of the lowest immunization coverage rates in the northern Nigeria, this DFID supported programme 
was started in November 2006 in four Northern States of the country; Jigawa, Katsina, Yobe and Zamfara 
States and the programme was billed to run for a five year period. 
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The key goal of PRRINN is to improve immunization coverage in a sustainable manner, with routine 
immunization system strengthening as an entry point for strengthening the PHC system. 
 
Some of the project development objectives (PDO) are:  
 to improve the capacity of the States and LGAs to plan, implement and monitor routine 
immunization activities within the context of integrated primary healthcare. 
 to increase access to the uptake of immunization 
 to strengthen community ownership of immunization activities 
 
The factors responsible for the failure of routine immunization in the country are multifaceted and can be 
placed under broad headings as ‘supply side issues’ and ‘demand side issues’.  The supply side issues 
include: the unavailability of vaccines, absence of vaccinators, and distance to the routine immunization 
facilities
27, 28
. The development partners also reported six other major factors which include; insufficient 
ownership by States, LGAs and communities, lack of commitment by all tiers of Government, lack of year-
round availability of all vaccines at health facility level, lack of monthly financial support to operational 
costs, lack of proper supervision and feedback, lack of data driven monitoring and low staff motivation 
(especially the outreach staff)
 29
. 
 
On the demand-side, the factors responsible for the poor uptake of immunizations as revealed by the theory 
based research conducted in six northern States include: psychological factors which showed the role myths 
and rumors played in obstructing immunization uptake, for example the belief that foreign country promote 
immunization with a hidden agenda, there is also misinformation about the number of vaccines to be taken 
and the side effects of these vaccines; community and systemic factors, for example the people are 
discouraged because of the lack of skill from immunization service providers and long waiting time at the 
service delivery points; and socio demographic and media factors, for example limited media exposure and 
access to public health facilities among the low income earners
26
. Comparing these aforementioned factors 
with what was reported by Centre for Disease Control and Prevention (CDC) on the factors that influence 
immunization rates, they also stated poverty / access to care issues, cultural approaches to health care, and 
missed opportunities
30
. 
 
PRRINN immunization activities started in the various States at different time and the programme was 
designed to address the above factors responsible for the failure of routine immunization in the four States of 
Yobe, Jigawa, Katsina and Zamfara where the programme is being implemented.  
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Before the PRRINN programme started in Jigawa state in October 2006, the following challenges were a 
common place in the State: PHC service budgets were inadequate to support staff supervision and training, 
drug supply, facility maintenance and health promotion
1
.  
 
However, after the commencement of PRRINN, the health systems strengthening objectives under listed are 
being implemented through various activities to address the challenges aforementioned:  
 
1. Advocacy and technical assistance to the state and local governments, political, traditional and 
religious leaders as well as support to communities to demand services. 
2. PRRINN support has been laying the foundation for well-funded and managed PHC services by 
providing technical assistance for quality services and by working with Federal, state and local 
government authorities to plan, budget and monitor funds and activities effectively.  
3. Technical support to state government to ensure the regular supply of vaccines at the health facilities. 
4. Improving the cold chain and related transportation system. 
5. Provision of technical assistance on training of health facilities staff on all aspects of routine 
immunization. 
It has been reported
31
 that the advocacy and technical assistance to government, political, traditional and 
religious leaders, also the support to communities to demand the immunization service are already yielding 
positive results. PRRINN support was also reported to be laying the foundation for well-funded and 
managed PHC services by providing technical assistance for quality services and by working with the three 
tiers of government to plan, budget and monitor funds and activities effectively.  
 
Other positive results reported include increase in regular vaccine supply to several health facilities and 
repairs to all solar panel installations which provide alternate electrical power source and ensured that the 
hot climate in the northern state does not destroy the vaccines.  Transport policies have been developed, 
health facilities staff have been trained and empowered to carry out a peer review of their PHC service 
delivery and the State Ministry of Health has begun regular supportive supervisory visits.  The report also 
revealed that communities are beginning to be empowered to learn about and discuss the benefits of utilizing 
modern health services and many mothers and children are beginning to go to health facilities for the first 
time in their lives.  The state is now said to have costed health plan and the 27 LGAs in the state now use 
detailed health plans and budgets to advocate for adequate funds release to the PHC. 
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In 2008, the PRRINN programme extended its scope to cover health care for mothers and children under the 
MNCH programme in order to add to the existing programme on improving routine immunization. The new 
PRRINN programme is now referred to as PRRINN-MNCH; this is made possible by the new fund from the 
Norwegian government. The purpose of the new PRRINN-MNCH programme is to improve the quality and 
availability of all maternal, neonatal and child health services
32
. The services cover the following: antenatal 
and postnatal care, safer deliveries, care for newborn and young children, better nutrition and routine 
immunization. Also in 2010, the PRRINN programme tenure was extended for an additional two years; the 
programme will now run for 7 years instead of the previous five years. The extension was based on the 
programme review. 
 
The original DFID funded PRRINN was borne to revive routine immunization and its mandate was to 
strengthen the RI system. It focused on: 
 building the cold chain through repair of solar fridges 
 strengthening the capacity of health facilities to deliver RI services through training of mid-level 
managers 
 developing and implementing micro-plans 
 supporting the development of transport policies and so on 
 development of the State plans for RI 
 
The detailed aim and output of the PRRINN programme and phases of implementation is detailed in the 
annual report for 2008 
31
.  
 
Some of the contributions of PRRINN and the other immunization partners in Jigawa State are detailed 
below under the following headings 
31, 32, 33
. 
 
Strengthening RI systems and services 
The government was assisted by PRRINN in repairing faulty solar systems across the State, facilitated the 
development of a multiyear immunization strategy for the State. Three hundred and thirty three motorcycles 
were purchased and distributed to Ward Focal Persons (WFPs) by State Government through the ministry of 
health. Technical support was provided by PRRINN to strengthen the management of the motorcycles that 
were distributed to WFPs for the monitoring and measuring the key performance indicators (KPI) to 
increase availability of vaccines for health facilities and outreach services in all the 288 wards and 
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communities in the State.  
 
The State shifted focus from IPD driven immunization programme to actual RI services. This was done 
through advocacy and support. The government released funds and other resources for immunization and RI 
services, made vaccine available in the health facilities, advocacy was increased to increase demand for 
immunization services in the State, and they also increased number of outreach immunization services.   
Significant improvement was noticed in this regards as early as in 2009 when the percentage of LGAs with 
stockout of vaccines was greatly reduced when compared with was happening in 2007. 
 
Increasing Budget Commitment 
The State Governor in 2008 released N45 million for RI activities, this also was followed with increased 
budgetary allocation from across LGAs toward RI activities. Jigawa State with the support of PRRINN 
accounted for the money spent under GAVI which enabled GAVI to release more funds for immunization 
activities. Generally fund were released effectively for immunization activities over the years and the 
immunization partners have been supporting the State government financially. 
 
Strengthening PHC System 
Priority was given to proper planning in the State. This led to the development of yearly operational plans 
for both the SMOH and the 9 Gundumas. Other planning tools that were developed with support from 
partners include HHR operational plan (norms), transport policy, the implementation of Integrated 
Supportive Supervision (ISS) system and operational HMIS meeting at the Gunduma level. 
 
The PHC system in Jigawa State was strengthened by the initiative of the National Primary Health Care 
Development Agency (NPHCDA) that was sold to the northern States, which was to bring PHC Under One 
Roof (PHCUOR). The PHCUOR concept has the following advantages: 
 It has a single management body with adequate capacity that has control over services and resources 
 Enabling legislation and concomitant regulations (inclusive of the key elements) 
 Decentralized authority, responsibility and accountability with appropriate span of control. Roles and 
responsibilities of the different levels will need to be clearly defined. 
 Principle of three ones (one management, one plan and one M&E system). 
 An integrated supportive supervisory system managed from a single source. 
 Integration of all PHC services under one authority – at a minimum consisting of health education 
and promotion, MCH/FP, immunization, disease control, essential drugs, nutrition and treatment of 
common ailments. 
 Effective referral system between/across the different levels of care. 
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A concept note was developed for PHCUOR implementation in 2009. A policy document and 
implementation guide was also drafted. This PHCUOR strengthened the PHC system by reducing the 
fragmentation of PHC service delivery.  
  
Strengthening Advocacy for Immunisation 
PRRINN and other partners play a significant role through HERFON to develop state level advocacy plans. 
In Jigawa State, the Informal Eminent Persons’ Group (EPG) was formed. The group is made up of mostly 
retired key senior officials who can advocate behind the scenes on key issues premised on immunization 
activities in the State.  
 
The partners working on immunization in Jigawa State also intensified advocacy by coming together to 
attend the Emirates Council to solicit support for RI and to reduce non-compliance in 2009.  The partners 
include State Ministry of Health, GHB, WHO, UNICEF, PATHS2 and PRRINN. 
 
Some other activities and intervention in the State include: 
 Free MNCH 
 Kangaroo mother care was initiated in the State 
 Community case management and IMCI  
 
On the emergence of the PRRINN-MNCH programme which is a combination of the DFID funded PRRINN 
and the Norwegian government funded MNCH projects in 2008, the focus changed to achieving the 
following seven main outputs
32
: 
 strengthen State and LGA governance of PHC systems geared to MNCH 
 improved human resource policies and practices for PHC 
 improved delivery of MNCH services via the PHC system 
 operational research providing evidence for PHC stewardship, MNCH policy and planning, service 
delivery and effective demand 
 improved information generation with knowledge being used in policy and practice 
 increased demand for MNCH services 
 improved capacity of Federal Ministry level to enable States’ routine immunization activities. 
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The focus of this study is only on the objective of the original DFID funded PRRINN programme at 
improving routine immunization in Jigawa State. 
 
2.6 Partnership for Reviving Routine Immunization in Northern Nigeria (PRRINN) Reviews and 
Peer and Participatory Rapid Health Appraisal for Action (PPRHAA)  
The review of PRRINN and MNCH was carried out in 2009 by representatives from several agencies and 
government departments (for multisectoral representation). The review consisted of a review of key 
documents and reports, interviews with PRRINN staff, key stakeholders at national, regional, State and LGA 
levels. After this review a scoring of the assessment was done, and the conclusion was that the output of the 
programme can achieve results in the shortest possible time
12
. A similar review was done in the following 
year and the programme successes were itemized in the review report 
13
.  
 
In 2009, PPRHAA exercise was carried out in Jigawa State and it involved 114 primary health facilities, 9 
general and cottage hospitals, and in the 9 GHB 
34
. The PPRHAA is a simple and rapid way of assessing 
performance at health facilities, identifying problems and achievements, from which managers and staffs 
prepare plans based on their needs, community priorities and within available resources. The appraisal 
usually involves building the capacity of managers and staff of the health facilities in appraising, analysing, 
understanding and implementing key aspects of health management. PPRHAA also involves strengthening 
the relationship between communities and health service providers’ 34.  
 
The PPRHAA revealed that 99% of health facilities in Jigawa State now provide RI on a weekly basis. It 
also revealed the availability of registers and other data collection tools in these health facilities; these have 
led to the improvement in data collection process. Some of the other findings of the PPRHAA include the 
improvement of the Drug Revolving Fund (DRF), the improvement of infection control system and 
improvement in waste management and general sanitation in the health facilities 
34
. The PPRHAA was seen 
as a tool for strengthening the primary health system and was going to be institutionalized in the State. 
 
 
 
 
 
21 | P a g e  
 
CHAPTER THREE 
 
3. Methodology 
 
3.1 Study Design  
This evaluation applies a before and after quasi experimental study design based on analysis of secondary 
data from the National Immunization Coverage Surveys (2006 & 2010) supplemented with primary data on 
routine immunization collected at the primary health facilities and also information from primary healthcare 
stakeholders in Jigawa State via key informant interviews. The stakeholders included the key Directors at 
the State Ministry of Health, key officers at PRRINN, Directors of PHC at the LGA level, key officials of 
Gunduma Health Board (GHB)
1
, Heads of health facilities, selected Heads of households and mothers of 
children aged 12 to 23 months.  
 
The quasi-experimental study design will allow for the evaluation of the intervention programme and will 
help to answer the third level research questions which deals with problems that seek to generate 
information about relationships, the ‘WHAT’ questions (‘what is the effect of a particular intervention or 
strategy’). This is the question that this research study seeks to answer. 
 
Quasi-experimental studies are used in the evaluation of the effectiveness of new programmes, or when a 
manager is evaluating an existing intervention programme or when development partners / agencies funding 
a programme wants to evaluate a programme for which no parallel control group exists
35, 38
. Quasi 
experimental study designs is appropriate to measure the impact of the public health intervention on a 
particular health outcome in the same populations
37
.  Repeating survey data collection can allow comparison 
across time which is often crucial for watching the progression of diseases and the effectiveness of 
preventive measures. Surveys are also widely used to evaluate public health interventions. They can be an 
effective evaluation tool and provide useful overviews of disease patterns or of an intervention
38
. 
 
3.2  Study Population  
All immunization data collected for children aged between 12 months to 23 months and mothers of children 
bearing age during the National Immunization Coverage Survey in Jigawa State and routine immunization 
data from selected primary health facilities in the State based on sample size determination for this study. 
The study population for the key informant interviews included the immunization stakeholders; key 
Directors at the State Ministry of Health, key officers at PRRINN national and Jigawa State offices, 
Directors of PHC at the LGA level, key officials of GHB, Heads of health facilities, selected Heads of 
                     
1
 Gunduma Health System is synonymous to District Health System in Jigawa State. 
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households and mothers of children aged 12 to 23 months 
 
3.3 Sample size 
The sample size included all the secondary data set from the randomly selected 7 LGAs covered during the 
immunization coverage survey in the State in 2006 and 2010. The sample size was achieved using two 
stages cluster sampling technique: at first stage, 7 LGAs were randomly selected to achieve 25% of the total 
LGAs and during second stage, random sampling was used to select clusters in communities using current 
community listings and population. The 7 LGAs covered were randomly selected using the tables made for 
cluster techniques (see Appendix 1).  The total Sample Size for the State was calculated using the formula 
below: 
 
Total sample size = Number of children per cluster x number of clusters 
 
The sample size for the primary data that was collected from the primary health facilities was estimated 
based on simple random sampling. The confidence level of 95% was chosen at the confidence interval of 
0.05. The study population is 623 (total number of public primary health facilities in Jigawa State); the 
overall sample size that was calculated using the simple random calculator is 238
39
. The sample size was 
calculated for each of the 27 LGAs and the total sample size arrived at is 236 PHFs (please see Table 3).  
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Table 3: Sample Size for primary data collection at primary health facilities 
S/No LGA 
Number of PHFs  
(Sample Population) 
Number of PHFs 
Sampled  
(Sample size) 
1 Auyo 23 9 
2 Babura 16 6 
3 Birnin Kudu 35 13 
4 Birniwa 20 8 
5 Buji 28 11 
6 Dutse 39 15 
7 Gagarawa 17 6 
8 Garki 22 8 
9 Gumel 13 5 
10 Guri 15 6 
11 Gwaram 60 23 
12 Gwiwa 18 7 
13 Hadejia 5 2 
14 Jahun 33 13 
15 Kafin Hausa 27 10 
16 Kaugama 17 6 
17 Kazaure 17 6 
18 Kiri Kasamma 21 8 
19 Kiyawa 37 14 
20 Maigatari 18 7 
21 Mallam Madori 23 9 
22 Miga 22 8 
23 Ringim 25 10 
24 Roni 13 5 
25 Sule-Tankarkar 22 8 
26 Taura 23 9 
27 Yankwashi 14 5 
  Total 623 237 
 
3.4 Sampling Procedure 
The sampling done for the collection of NICS data was based on the WHO developed 30 x 7 cluster 
sampling technique. A two stage sampling was done; during the first stage, 25% of the total number of 
LGAs in the State was randomly selected; at the second stage, thirty clusters in each selected LGA were 
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selected randomly. The selection of the LGAs was done using random sampling formula based on 
Probability Proportionate to Size (PPS). The technique allows a small sample (number) of the study 
population to be sampled thus providing statistically valid data that can be extrapolated to the whole study 
population
35
. Applying the technique, the study population was first divided into clusters (collection of 
communities / households within each LGA). The LGAs selected were divided along the line of 
communities (24 communities were selected in all). Twenty six clusters were randomly selected from the 24 
selected communities and a total of 780 households were visited to administer questionnaires (see table 4). 
 
    Table 4: Selected Clusters and Communities for NICS 2010 in Jigawa State 
LGA Name 
No. of communities in 
the LGA 
No. of 
communities 
selected 
No of 
Clusters 
selected 
No. of 
questionnaires 
administered 
Birnin Kudu 48 3 3 90 
Dutse 50 4 4 120 
Gumel 39 3 3 90 
Jalum 66 4 4 120 
Kazaure 148 3 4 120 
Miga 104 4 4 120 
Taura 34 3 4 120 
Total 489 24 26 780 
 
The first house visited in each cluster (e.g Yalwan-Damai community in Birnin Kudu LGA) was selected at 
random using existing list of household names in the community.  In Kazaure community with more than 
one clusters selected, the community was divided geographically into non-overlapping areas with clear 
boundaries. After which the first cluster was randomly selected, eligible individuals were then sampled from 
within the cluster and subsequent clusters
36
. The eligible individuals from the clusters were mothers of 
children aged 12-23 months (for the information on BCG, OPV and DPT vaccines immunization) and 
women of childbearing age (between 15 and 44 years old) for the TT vaccine.  
 
3.5 Selection of Survey Personnel 
The survey personnel used for data collection of the routine immunization data from the primary health 
facilities were trained data collectors, most of which are the malaria focal persons in each of the selected 
LGAs. They know the objectives and the sensitivity involve in conducting research. The selection of the 
survey personnel was based on academic background (health / social sciences with at least national diploma 
degree OND), maturity, relevant survey experience, human relation ability and understanding of the culture / 
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norms of the communities in which the primary health facilities are located.  
 
3.6 Data Collection 
The following immunization indicators were extracted from NICS data for 2006 and 2010: 
 BCG Coverage (Bacille Calmette-Guerin, existing TB vaccine) 
 OPV 0-3 Coverage (Oral Polio Vaccine) 
 DPT 1-3 Coverage (Diphtheria, Pertusis and Tetanus) 
 Hepatitis B (HepB) Coverage 
 Measles 
 Tetanus Toxoid Vaccine Coverage 
 
The findings from the in-depth interviews carried out using semi structured questionnaires collated and 
analyzed to complement the finding from the analysis of the secondary data on immunization and the 
primary data.  
 
Selected PHFs were visited and the health facility data collection instruments were administered to capture 
information about routine immunization from the health facilities across the 27 LGAs. This field data 
collection phase involved two data collectors per LGA and nine Supervisors for the whole State (one 
Supervisor supervised data collection in three LGAs). This was to ensure proper management and 
coordination and to minimize errors.  
 
3.6.1 Data Collection Instruments 
For the secondary childhood immunization data used for this study, a structured questionnaires (see 
appendix 2 & 3) was developed to collect information on a child’s date of birth and immunization history for 
BCG, DPT (1 – 3), OPV (OPV 0 – 3), Hep B (HBV 1 – 3), Yellow fever, and Measles vaccines. The 
structured questionnaires for TT collect information on number of pregnancies, number of TT doses 
received in prior to and during the last pregnancy. The sources of immunization were also captured in the 
questionnaires. 
 
For the selected PHFs a structured questionnaires (see appendix 4) was developed, pre-tested and modified 
to collect information on availability of RI equipment, personnel, records keeping, RI records over 3 years, 
RI consumable (stock) and training on RI. The interview guide was also developed (see appendix 5).  
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3.6.2 Pre-testing of data collection instruments  
To ensure validity, the data collection instrument (see appendix 4) was pre-tested in another northern State 
(Kano) from which Jigawa State was created. The pre-testing of the draft instruments was done in order to 
determine the lucidness of the questions. The pre-testing pointed out the weakness of the draft instruments 
was pointed out as lacking the ability to compare data over the period of interest (2005 to 2011). Some of 
the questions that were rephrased include the following: 
Question 3b: Were the cold chain equipment in 2005 and 2006 adequate?  
This was introduced after the pre-testing. 
 
Question 8: How many children were immunized in the last three months?  
This question was rephrased to accommodate the period for comparison:  
How many children were immunized in this health facility in? 
 2005 2006 2011 
Number of children 
immunized? 
   
 
Similar tables were introduced for questions 9 and 11 to allow for comparison of data over the period. 
Hence the data collection instrument was redesigned based on the lapses noticed and the advice of the 
immunization expert who doubles as the co-supervisor for this study.  
 
For the data collection instruments used to collect the secondary immunization data, we are aware that the 
Survey instrument was standardized by the World Health Organization (WHO) for the purpose of 
immunization coverage. 
 
3.7 Validity and Reliability  
Validity: questions if the study is measuring what it says it is measuring. The components that could 
question the validity of the study include bias (selection bias and measurement bias) and confounders and 
these have been minimized by the sampling technique used for this study. The sampling technique used 
during the original data collection process for the secondary childhood immunization data set allows for the 
control of bias via randomization of the sample for the immunization coverage survey. The validity is also 
strengthened by the standardization of questionnaires used in the survey to include previously validated 
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questions described by the WHO.  
 
Reliability: this questions if the study is measuring things consistently. The reliability of the immunization 
coverage survey data will be assumed to be assured based on the design that allowed for repeating the 
process of data collection in selected clusters by a different set of data collectors. The Supervisors for the 
fresh routine data collection at the primary health facilities also repeated data collection at selected health 
facilities to ensure reliability.  
 
3.8 Data Management and Analysis  
 
3.8.1 Quality Assurance and Control 
Data entry tasks and management was handled by the lead researcher and the data entry personnel. Data 
cleaning was done in two stages. First, the field coordinator confirmed the completeness and thoroughness 
of records each day the filled data collection instruments were submitted. Secondly, checks for consistency 
of responses were carried out on data files via double entry technique.   The raw data were referred to before 
corrections were made on any identified error. 
 
The field coordinator also paid unscheduled visits to three selected facilities for back-checking and data 
validation using the same questionnaires earlier used. 
 
3.8.2 Data Analysis  
 
Data Processing 
The data collected from the field and extracted from the NICS data set was cross checked by the field team 
supervisors’ and by the data management personnel before data entry and analysis. The raw data was then 
entered into the software by the trained data clerks for the analysis to be done. The data extracted from the 
immunization coverage was analyzed using a specialized software design for coverage survey, Coverage 
Survey and Analysis Software (COSAS).  The data files were then converted to the format which Epi Info 
analytical Software can process. After the analysis by Epi Info, the files were merged and exported to the 
COSAS software for final analysis. The COSAS software then provided standard reports after it has 
automatically analyse the data. The standard reports from COSAS show the main indicators for child 
immunization. These include: 
 Coverage summary table: crude and valid coverage by dose; 
 Detailed dose status table: valid and invalid dose result; 
 ‘‘Missed opportunities’’ summary table; 
 Coverage analysis for measles; 
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 Date distribution table for the first dose of Oral Polio Vaccine (OPV1); 
 Date distribution table for measles; 
 Age distribution table for measles and TT immunization; 
 Coverage summary table: crude and valid immunization; 
 Detailed dose status table: valid and invalid dose result, and 
 A line list of results by cluster 
 
Comparative analysis using paired samples t-test was done between the routine data from the health 
facilities before and after the implementation of PRRINN activities in Jigawa State.  
 
3.9 Ethical Considerations  
All ethical codes of behavior guiding research programmes were applied in the course of this research study. 
We respected the autonomy of the participants; the consent of the health care providers was sought as an 
introductory letter was given to them and a consent form was also presented and signed by them before the 
health facility questionnaires were administered on them. All the people interviewed during this research 
study were told they have the right to decline to the interview if they so wish. Above all, the research ethics 
committee under the department of Policy, Planning and Resource Mobilization in the Jigawa State Ministry 
of Health gave their approval before data were collected at the selected primary health facilities. Also ethics 
approval was granted by the UWC Senate Research and Ethics Committee and also the National Health 
Research Ethics Committee of Nigeria (NHREC) (See appendix 6).  
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CHAPTER FOUR 
 
4. Results 
The findings from this research study are presented in this chapter under the following sub-headings in line 
with the study objectives: 
 
 Current Status coverage for Jigawa State 
 Immunization drop-out rate in Jigawa State 
 Comparison of RI over time in Jigawa State 
 Comparison of routine data with survey data 
 
4.1  Current Status of Immunization Coverage for Jigawa State 
 
4.1.1 Fully Immunized Children 
Jigawa State FIC performance is presented in the table 5. The crude coverage for FIC is 76.8% in the State 
for 2010 but the valid coverage 16.4%. 
 
4.1.2 Immunized Children against Tuberculosis 
Based on the NICS 2010 survey, BCG coverage showed high percentage coverage for Jigawa at over 75% 
for crude coverage with 66% of the children having the BCG scar to show for it (see table 5).  
 
4.1.3 Immunized Children with DPT 3 
The NICS survey report indicates that Jigawa State recorded a seemingly high DPT 3 coverage at over 80% 
for crude coverage (card + history). When all the DPT figures are considered for Jigawa State, there is a 
drop-out of about 6% between DPT 1 and DPT 3. It confirms a generally strong routine immunization 
system where the immunization access and service uptake have greatly improved (please see section on 
drop-out rates).  
 
4.1.4 Immunized Children with OPV 3 
Jigawa State recorded OPV3 coverage well above the national average for crude coverage at 88% compared 
to the national coverage of 74%. 
 
4.1.5 Immunized Children with Measles Vaccine 
Jigawa State recorded measles vaccine coverage of 85.1% in 2010.  
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4.1.6 Immunized Children with Hepatitis B3 Vaccine 
The coverage reported for Jigawa State is over 85%. 
 
         Table 5: Current Status of Immunization Coverage for Jigawa State 
Proportion of 
fully immunized 
children (12 – 
23months) in 
2010 (extracted 
from NICS 2010 
data) 
Crude Coverage Percent (%) fully immunized by card 
or history  76.8 
Percent (%) fully immunized by card 63.1 
Valid Coverage 
by 52 weeks 
Percent (%) fully immunized by card 
or history 16.4 
Proportion of 
children 
immunized 
against 
Tuberculosis 
(BCG) in 2010 
Crude Coverage Percent (%) fully immunized by card 
or history  92.9 
Percent (%) fully immunized by card 76.2 
Children with 
BCG Scar 
Percent (%) 
66.1 
Proportion of 
children 
immunized with 
DPT3 in 2010 
Crude Coverage Percent (%) DPT3 immunization by 
card or history 88.7 
Percent (%) DPT3 immunization by 
card 
68.5 
Valid Coverage Percent (%) DPT3 immunization by 
card or history 
58.4 
Proportion of 
children (12-23 
months) 
immunized with 
OPV3 
Crude Coverage Percent (%) immunized with OPV3 by 
card or history 88.1 
Percent (%) immunized with OPV3 by 
card 
69.1 
Proportion of 
children (12-23 
months) 
immunized with 
Measles Vaccine 
in 2010 
Crude Coverage Percent (%) immunized with measles 
vaccine card or history 85.1 
Percent (%) immunized with measles 
vaccine by card 
66.7 
Valid Coverage 
at 9 months 
Percent (%) immunized with measles 
vaccine by card 
14.3 
Proportion of 
children (12-23 
months) 
immunized with 
Hepatitis B3  
Vaccine in 2010 
Crude Coverage Percent (%) immunized with HB3 by 
card or history 87.5 
Percent (%) immunized with HB3 by 
card 68.5 
 
4.1.7 Tetanus Toxoid Vaccine Coverage 
The percentage of women with at least 2 doses of TT received during their lifetime in Jigawa State is 64.3%. 
The drop-out rate of TT for between TT1 to TT5 is also on the high side at 58.1%. 
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4.2  Immunization drop-out rate in Jigawa State 
The continuity or the follow-up of immunization programme is measured by the drop-out rates between 
doses of antigens. For the purpose of this study, two drop-out rates considered: 
 Drop-out from DPT1 to DPT3 
 
The drop-out rates for Jigawa State for DPT1 – DPT3 is 6.0%. 
  
4.3  Comparison of routine immunization over time in Jigawa State 
Table 6 compares the 2006 and 2010 coverage data. 
 
Table 6: Comparison of immunization coverage between 2006 and 2010 
ANTIGEN/ 
INDICATOR 
CRUDE COVERAGE 
% 
VALID COVERAGE 
% 
CARD + HISTORY CARD CARD + HISTORY 
 2006 2010 Change 2006 2010 Change 2006 2010 Change 
FIC 15.5 76.8 61.3 5.8 63.1 57.3 4.4 16.4 12.0 
DPT3 28.9 88.7 59.8 15.9 68.5 52.6 15.6 58.4 42.8 
OPV3 44.8 88.1 43.3 14.7 69.1 54.4 - - - 
Hepatitis B3 17.3 87.5 70.2 5.1 68.5 63.4 - - - 
BCG 31.3 92.9 61.6 25.4 76.2 50.8 
Children with BCG Scar 
24.0 66.1 42.1 
Measles 
vaccine 
47.9 85.1 37.2 23.1 66.7 43.6 
Valid Coverage at 9 
Months 
16.0 14.3 -1.7 
 
4.4 Paired samples t-test for the immunization coverage between 2006 and 2010 
Paired samples t-test analysis was carried out for the crude coverage rates of FIC, DPT3, OPV3, Hepatitis 
B3, BCG and Measles vaccines. 
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Assumption 
Null hypothesis: there is no significant difference between the means of the coverage rates for 2006 and 
2010  
Alternate hypothesis: there is significant difference between the means of the coverage rates for 2006 and 
2010. 
 
The SPSS output of the paired samples t-test  is displayed in tables 7 and 8 below. 
 
Table 7: Paired samples correlations  
 N Correlation Sig. 
Pair before & after 6 0.364 0.478 
   
Table 8: Paired samples test 
 
Paired Differences 
t df 
Sig. (2-
tailed) Mean 
Std. 
Deviation 
Std. 
Error 
Mean 
95% Confidence 
Interval of the 
Difference 
Lower Upper 
Pair 1 
before –
after 
-55.5667 12.5629 5.1288 -68.7506 -42.3827 -10.834 5 .000 
@ 95% Confidence Interval 
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                Figure 1: Comparison of Crude Coverage of fully immunized children (12-23 months)  
     between 2006 and 2010 
 
 
 The graph shows that there was an obvious change in the crude coverage rate for fully immunized children 
in Jigawa State with 76.8% coverage rate recorded in 2010 compared with the 15.5% coverage in previous 
survey in 2006.  
     
    Figure 2: Comparison of crude coverage of children (12-23 months) immunized  
               against BCG between 2006 and 2010 
 
 
The findings showed that the crude coverage for BCG in 2006 was 31.3% in Jigawa State while it grew up 
to 92.9% in 2010.   
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      Figure 3: Comparison of proportion of children (12-23 months) immunized against OPV 3, DPT 3                
      and HBV 3 between 2006 and 2010 
 
 
When the trivalent vaccines and hepatitis vaccine coverage rate were compared for 2006 and 2010, the 
findings showed that the coverage rate increased from 45% to 88% and from 29% to 89% for the trvivalent 
OPV3 and DPT3 respectively. The Hepatitis B3 vaccine coverage also increased from 17.3% to 88% 
coverage rate.   
 
     Table 9: Comparison of children immunized with Tetanus Toxoid Vaccine  
      between 2006 and 2010 
COVERAGE FOR AT LEAST 2 DOSES OF TT 
CARD  
2006 2010 Change 
9.0 64.3 55.3 
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            Figure 4: Comparison of children immunized with Tetanus Toxoid Vaccine between  
            2006 and 2010 
 
 
Findings revealed that the coverage of women who received atleast two doses of tetanus toxoid before child 
delivery increased from 9% in 2006 to 64.3% in 2010.  
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4.5  Comparison of routine data with survey data 
 
Comparison between survey and routine data showed that there are differences between reported coverage 
rates. The routine data extracted from the 2009 Annual report of PRRINN 
31
 gave different coverage rates 
when converted using the population figures estimates as reported in the State profile
2
.  
 
Table 10: Comparison of routine immunization data and the survey based immunization data 
Data Element 
2009  
(end Sept) 
2009  
(predicted) 
2009  
(Routine Data 
Immunization 
Coverage ) 
2010  
(Survey Data Immunization 
Coverage) 
    
Crude 
(Card + 
History) 
Crude 
(Card) 
Valid 
Coverage 
(Card + 
History) 
DPT < 1 year 34,138 58,522 31.6% 87.7% 68.5% 58.4% 
Fully Immunised 
child < 1 year 
29,690 50,897 27.5% 76.8% 63.1% 16.4% 
Tetanus Toxoid2 
or booster to 
pregnant women 
17,939 30,753 13.3%    
 
The noticed differences could be attributed to unreliable population estimates, compromising the calculation 
of catchment areas for immunization services and also the routine data used is for 2009 while the survey 
data is for 2010. 
 
4.6 Health facilities routine data and other immunization information in the State 
The research study also probed into the immunization services supply side issues by asking for available 
data on vaccine availability across the service delivery points in the State, vaccine management, and 
availability of microplans in the health facility and LGA. The extracted data on the Rapid Immunization 
Assessment (RIA) carried out in the State is presented below. The data compared the situation in 2007 to 
that of 2009 when the RIA was done. 
     
       
                     
2
 Total population = 4,631,416; population of 0 – 59 months = 926,283; population of Under 1 year = 185,217;  
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     Table 11: Immunization Supply Side Assessment 
Description 2007  2009 
LGA Stores with stock outs of 
BCG vaccine (percentage reporting 
yes) 
38% 25% 
LGA Stores with stock outs of TT 
vaccine (percentage reporting yes) 
100% 25% 
Health Facilities with stock outs of 
BCG vaccine (percentage reporting 
yes) 
74% 50% 
Health Facilities with stock outs of 
BCG vaccine (percentage reporting 
yes) 
61% 13% 
 
The findings showed that there was reduction in the frequency of vaccines stock outs in the LGA stores and 
health facilities across the State. Tetanus Toxoid vaccine that was completely out of stock in 2007 is now 
readily available across the State and the number of LGA stores reporting stock outs have reduced 
drastically. 
 
4.7 Counterfactual analysis of Immunization coverage in Jigawa and two other northern States 
The intensed immunization programme has implemented by PRRINN and other partners in Jigawa, Katsina, 
Yobe and Zamfara was not done in some other States with similar poor immunization indicators prior to the 
year 2006. This study extracted a few immunization indicators from the NICS reports (2006 and 2010) and 
compared over similar period has done for Jigawa State. The immunization coverage for Sokoto State which 
is located in the same geopolitical zone with Jigawa State and Bauchi State which shares border with Jigawa 
State was compared for FIC, BCG, DPT3 and DPT1 – DPT3 drop-out rate. 
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Table 12: Comparison of coverage of fully immunized children (12-23 months) between 2006 and 2010 
for Jigawa, Sokoto and Bauchi States 
 STATE CRUDE COVERAGE 
VALID COVERAGE BY 
52 WEEKS 
 
CARD + HISTORY CARD CARD + HISTORY 
 2006 2010 Change 2006 2010 Change 2006 2010 Change 
Jigawa 15.5 76.8 61.3 5.8 63.1 57.3 4.4 16.4 12.0 
Bauchi 29.8 25.6 -4.2 13.6 21.9 8.3 11.0 4.2 6.8 
Sokoto 5.4 31.8 26.4 1.5 6.9 5.4 0.0 16.3 16.3 
 
From the comparison made on FIC in the States chosen where no intense PRRINN and partners activities 
was not present, the changes noticed was small when compared with the changes noticed in Jigawa State 
under the same period. 
 
  Table 13: Comparison of children immunized against Tuberculosis (BCG)  
  between 2006 and 2010 
STATE CRUDE COVERAGE 
 
CARD + HISTORY CARD 
 2006 2010 Change 2006 2010 Change 
Jigawa 31.3 92.9 61.6 25.4 76.2 50.8 
Bauchi 63.1 35.4 -27.7 9.2 51.3 42.1 
Sokoto 14.4 57.0 42.6 9.8 18.8 9.0 
 
The difference noticed in the BCG coverage across the other two States was not as high as for Jigawa State 
where the immunization intervention program of the PRRINN and other partners took place. 
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       Table 14: Comparison of proportion of children (12-23 months) immunized with DPT 3  
       between 2006 and 2010 for Jigawa, Sokoto and Bauchi States 
STATE CRUDE COVERAGE VALID COVERAGE 
 
CARD + HISTORY CARD CARD + HISTORY 
 2006 2010 Change 2006 2010 Change 2006 2010 Change 
Jigawa 28.9 88.7 59.8 15.9 68.5 52.6 15.6 58.4 42.8 
Bauchi 37.7 42.0 4.3 17.8 31.2 13.4 25.1 74.2 49.1 
Sokoto 9.2 54.2 45 2.8 10.3 7.5 5.3 18.0 12.7 
 
The comparison made on the proportion of children immunized with DPT 3 vaccine in the three States also 
showed a marked difference in the changes noticed in the percentage coverage for DPT 3 between the 
implementing year of the immunization intervention programme. 
 
Fig 5: Counterfactual analysis of the differences noticed in immunization coverages between Jigawa 
State and two other States (Bauchi and Sokoto) where there were no PRRINN immunization 
revitalization programmes. 
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CHAPTER FIVE 
 
5. Discussion 
The discussion and interpretation of the findings is discussed in this chapter. The discussion is structured to 
describe the main objectives of the study and the approach to the analysis. The findings were then 
interpreted in line with the objectives of the study under similar sub-headings used in presenting the analyses 
of the findings in the previous chapter.  
 
This study assessed the performance of routine immunization in Jigawa State to demonstrate the 
effectiveness of the DFID funded PRRINN component of PRRINN-MNCH activities in the State by 
comparing the immunization coverage before the commencement of the programme to date. The main 
objectives of this study were to ascertain the current status of immunization coverage for Jigawa State and 
compared this with the immunization coverage of the State in 2006; determination of immunization access 
and continuity using the drop-out rates of DPT antigen and determination of the current status of routine 
immunization in the health facilities. 
 
This study was able to ascertain the immunization coverage status for Jigawa State and compared it with 
coverage for 2006 which is taken as baseline before the commencement of PRRINN. The drop-out rates was 
determined, however, due to circumstances relating to the State research ethics, fresh routine data from 
selected health facilities could not be used in this study. Hence, the study depended on previous health 
facilities routine immunization data collected in 2009.  
 
From the different data presented under the findings, it was evident that there is an increase in immunization 
coverage in Jigawa State. This assertion is in line with the report of NICS 2010 which reported increases in 
the national coverage for fully immunized children and other vaccines with varying degree of coverage rate 
21
. The trend of the reported data in this study is also affirmed by the figures in the National Demographic 
Health Survey of 2008 for the national and zonal coverage rates 
41
. The findings in this study shows that the 
concerted effort of the immunization partners in the State in strengthening the PHC system and improving 
routine immunization in the State seem to have yielded fruits with the findings reported in this study. This is 
an indication of an improved immunization system and increased demand for the immunization services 
33
.  
There is however paucity of comparable pertinent information in the literature to discuss the findings of this 
study. 
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Overall Improvement in Routine Immunization 
Looking at the data gathered and presented in this study, it is clear that there is improvement in the 
immunization coverage and performance of the immunization system in Jigawa State. The over 60% 
increment in the percentage of fully immunized children from the 2006 coverage rate evidences this 
improvement. There has been over 300% increase in the number of children that received full complements 
of the required 6 antigens in the State since the creation of PRRINN. 
 
The crude coverage for FIC, which is not dependent on specified age, timing and or dosage intervals as 
prescribed in the national schedule, is 76.8% in the State.  However, the FIC figure for crude coverage 
dropped from 76.8% to 16.4% when the validity of the vaccine immunization is considered. The quality of 
immunization services which is measure by the reported figure for FIC with valid doses before 52 weeks of 
age showed that only 16% of children were immunized as required by the schedule. This is just a pointer to 
an immunization service system that is on the way to recovery. 
 
The first contact to immunization delivery system is measured by the number of children immunized with 
BCG and this gone up by about 61.6% over the four year period during the implementation of the PRRINN 
and immunization partners programme in the State. The reported figure in the NICS 2010 survey showed 
high percentage coverage for Jigawa at 92.9% for crude coverage with 66.1% of the children having the 
BCG scar to show for it. It shows that access to immunization services in the State has greatly increased.   
 
DPT 3 
DPT 3 is the third dose of the DPT vaccine which according to the national schedule is expected to be given 
at 14 weeks. It is a globally accepted indicator to assess immunization coverage trends. A child who was 
recorded as having been given DPT 3 is expected to have gone through the complete cycle of routine 
immunization and he/she is expected to have received the other vaccines (BCG, OPV 1 – 3 and DPT 1 – 3). 
In some instances, across the immunization offices in Nigeria, DPT 3 is usually used routinely to report FIC 
since the factual FIC coverage can only be gotten during surveys which are not done yearly.  
 
Hence, the DPT 3 coverage is usually used to measure the strength of the immunization programme in 
Nigeria 
4
. Looking at the DPT3 coverage for Jigawa State (88.7) which increased by about 59.8% over the 
2006 coverage, it is obvious that the immunization intervention programme has contributed positively to 
improving the immunization programme in the State.    
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OPV3 
OPV 3 is the third dose of the polio vaccine expected to be given to a child at 14 weeks according to the 
national immunization schedule. Polio which has been reported to be endemic in the northern part of the 
country
1
 witnessed an effective combating mechanism through routine immunization services and IPDs 
activities. This is evident in the oral polio vaccine coverage rate reported for 2010 in Jigawa State which is 
slightly above 88% for all children; this gave 43.3% increment over four year period. It shows an 
improvement in the ability of the immunization service delivery system to give valid doses of vaccines to 
infants.  
 
Measles vaccine coverage 
Measles vaccine which is administered as a single dose is the last antigen to be given to a child is used as an 
indicator to assess the ability of the delivery system to reach children before their first birthday. The 
performance of Jigawa State according to the NICS 2010 report showed an encouraging coverage when the 
crude figure was considered. It is shows that 85% of children were reached before their first birthday in the 
State. This is a pointer to an improved routine immunization system. 
 
Hepatitis B3 Vaccine Coverage 
This is the third dose of hepatitis vaccine administered at 14 weeks. The vaccine is known to be one of the  
most expensive vaccines in the world. The reported hepatitis B3 coverage for Jigawa was encouraging at  
87.5% which indicates that over 80% of the children were immunized with the vaccine. 
 
Tetanus Toxoid Coverage 
Tetanus is known to be a major contributor to high infant morbidity and mortality in the neonatal phase, 
therefore Tetanus Toxoid vaccine administration to pregnant women causes the formation of antibodies 
which provide protection to the neonates against neonatal tetanus. The administration of two doses of TT 
within a four week interval period in pregnancy is essential as this will produce enough antibodies to last the 
mother against Tetanus for 3 years while it is sufficient for the infant protection just before the 
administration of DPT at 6 weeks of age. This is best measured in two ways: 
 Mother protection: mothers that have received at least two doses 
 Child protection: children born to an eligible mother that have received at least two doses of TT 
before the child’s delivery 
TT immunization coverage is dependent on entries by immunization card only because of the strict time 
restrictions which is applied to administration of the two doses. 
 
The mother and child protection against tetanus toxoid measured by administration of at least two doses of 
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TT was also evidently increased from 9% coverage in 2006 to over 64% coverage in 2010. This is over 55% 
increment over the four year period. This shows that more mothers and infant are protected from morbidity 
and mortality associated with tetanus which is known to cause high mortality rate. 
 
Immunization Access and Utilization 
The immunization access and functionality was shown to have improved. The improvement noticed is due to 
increased in demand for immunization service which is met with a better system quality and utilization 
which is shown in the observed reduction in the drop-out rates. This shows that the effort of the various 
immunization programmes in the State (including PRRINN) on advocacy has yielded positive results, as 
more people access the immunization services and continuity is sustained. Some of the factors that were 
found to be responsible for immunization drop-out rates (like availability of vaccines, lack of information on 
the immunization schedule, distance to PHC providing RI, time and/awareness of need to return for 
subsequent doses, fear of vaccine side reactions etc) were all addressed effectively in the implementation of 
the immunization intervention programme in the State.  
 
The findings reported in this study confirm the report of the Peer and Participatory Rapid Health Appraisal 
for Action (PPRHAA) exercise that was conducted in 2009 in 114 primary health care facilities, 9 general 
and cottage hospitals and in 9 Gunduma Council of Jigawa State 
34
. The PPRHAA reported that there is 
improvement in PHC system and RI services in the health facilities as it was recorded that about 99% of all 
primary health facilities provides routine immunization services on weekly basis
34
. Improvement in the 
availability of registers and other data collection tools in the health facilities was also reported while the 
PHC system via the Drug Revolving Fund (DRF) scheme was sustained, infection control system are now 
integrated into the PHCs across the State. 
 
Paired T-Test 
The hypothesis test conducted for the immunization coverage rates difference between 2006 and 2010 to test 
the null hypothesis that the PRRINN and other partners’ immunization programme in the State led to an 
increase in immunization coverage in Jigawa State. The crude coverage rates of FIC, DPT3, OPV3, 
Hepatitis B3, BCG and Measles vaccines were used.  
 
Null hypothesis: there is no significant difference between the means of the coverage rates for 2006 and 
2010 i.e. PRRINN and other partners immunization programmes was not responsible for the increase in 
immunization coverage in the State. 
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Alternate hypothesis: there is significant difference between the means of the coverage rates for 2006 and 
2010 i.e. PRRINN and other partners immunization programmes was not responsible for the increase in 
immunization coverage in the State. 
 
The paired samples correlation showed a weak positive correlation at 0.364.  
The T value = -10.834 
We have 5 degrees of freedom 
Our significance is .000 
Since the significance value is less than .05, it means there is significant difference, hence the rejection of  
null hypothesis set is not accepted. It then means that the PRRINN and other partners programmes on 
improving immunization in Jigawa State was responsible for the increased immunization coverage noticed 
in the State in 2010. 
 
Limitations: The effect of other partners such as WHO, UNICEF and government effort on the status of 
routine immunization is a limitation that this study was faced with. Though the study aim was linked to the 
assessment of the effectiveness of PRRINN in Jigawa State, the study found out that other partners and 
government programmes in the State also contributed to the improvement of routine immunization. Hence, 
this became a confounding factor that could not be separated from the direct effect of the PRRINN 
programme on routine immunization.  
 
The other limitation experienced was the inability of the study to use the fresh routine data from selected 
health facilities to validate the other source of data got during the study. This was due to the inability of the 
research ethics committee under the auspices of the department of policy, planning and resource 
mobilization in the State ministry of health to grant the approval to use the routine data as at the time of this 
study. Hence, the study depended on previous health facilities routine immunization data collected in 2009. 
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CHAPTER SIX 
 
6.1 Conclusion 
The research study started with the intention of measuring the performance of routine immunization in 
Jigawa State on the backdrop of the involvement of PRRINN in reviving routine immunization as the name 
suggests. The study however, soon discovered that it can only be said that the improvement noticed in RI in 
the State is a collaborative efforts of all partners (State Ministry of Health, Gunduma Health Board, World 
Health Organization, United Nations Children Fund, Partnership for Transforming Health Systems and 
PRRINN). Hence, contribution rather than exclusive attribution was what the study deduced for the role 
PRRINN played in reviving routine immunization in Jigawa State. The collaborative efforts of all partners in 
improving routine immunization yielded a very positive result which is obvious in the State performance as 
regards immunization coverage rates and the presence of sound primary health healthcare structure and 
system in the State. 
 
To validate the above conclusion on linking the improvement in immunization performance in Jigawa State 
to the intervention from PRRINN and other partners that worked in the State to improve immunization 
activities, we used a hypothetical counterfactual analysis of the immunization data for States within the 
region that PRRINN was not active. The immunization data for these States (Bauchi and Sokoto) were 
compared for 2006 and 2010 (see table 12 to 14 & figure 5). What the study found out was that there was a 
marked difference in immunization coverage performance for Jigawa State compared to the coverage 
difference noticed in the other two States. 
 
We can draw the conclusion that the PRRINN and other immunization intervention programmes have been 
effective as evident by the positive improvement noticed in the immunization coverage performance of the 
State. This improvement and effectiveness displayed by the activities of PRRINN and other immunization 
intervention programmes in Jigawa State is similar to the success of the EPI programme in Port Harcourt as 
reported by Oruamabo and okoji in 1987 
25
. Just like the EPI program by design provided parents with 
information and making immunization available at times and places convenient to mothers and children, the 
PRRINN and partners programmes strengthened the RI systems and services across the States and make all 
the immunization services in all health centers functional. It further ensures proper advocacy and 
information sharing that increased immunization access in the State.  
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Significance of the study 
The significance of this study is shown in using survey based data to measure performance and effectiveness 
of intervention programmes targeted at improving immunization activities. Like it was reported by Stephen 
Lim and colleagues in 2008
23
 that survey based immunization coverage are a better indicator to monitoring 
progress of an intervention as it is not within the control of the managers of such programmes; hence issues 
such as over-reporting of data will be minimal.  
 
6.2 Recommendations 
Some recommendations arise from this study: 
 The State should commission more health facility and community based surveys to ascertain the 
State of routine immunization in the State in order to monitor actual progress 
 The department of policy, planning and resource mobilization under the State ministry of health 
should ensure prompt approval for research studies in the State 
 The Jigawa State Ministry of Health under the auspices of the State government and partnership it 
has enjoyed must ensure continuity of the routine immunization revitalization programme and 
sustained the gains of the programmes 
 The State government should be prepared to take over full responsibility for most of the partners 
funded activities under immunization should the tenure of the partners expires in the State. 
 The other neighboring States should emulate Jigawa State model by implementing similar 
programmes to improve routine immunization in their States 
 
 
 
 
 
47 | P a g e  
 
References 
 
1. FBA Analysts (2005). The State of Routine Immunization services in Nigeria and Reasons for Current 
Problems. Commissioned by DFID. Revised Version, Abuja, DFID 
 
2. Population Commission (NPC) [Nigeria] and ICF Macro. (2009). Nigeria Demographic and Health 
Survey 2008. Abuja, Nigeria: NPC and ICF Macro 
 
3. UNICEF/WHO/the World Bank/UN DESA Population Division. (2010). ‘Levels & trends in Child 
Mortality – Report 2010. Estimates developed by the UN Inter-agency Group for Child Mortality 
Estimation. New York 
 
4. National Programme on Immunization (2007). National Immunization Coverage Survey, 2006. Abuja, 
Nigeria: NPHCDA. 
 
5. Health topics (immunization): www.who.int/topics/immunization/en/ 
 
6. Battersby A. & Feilden R. (2005). Project to Revitalize Routine Immunization: Design of Routine 
Immunization Initiative. FBA Health System Analysts. 
 
7. Nigerian Demographic and Health Survey (1990). Demographic and Health Surveys. Federal Office of 
Statistics, Lagos, Nigeria, 1992 
 
8. Battersby A. (2001). Aspects of Immunisation in Nigeria. Abuja: Early Start Initiative/DFID. 
 
9. www.naijapals.com/modules/naijapals/nigeria/topic.39198.0.htm 
 
10. Budget Office of the Federation. (2011). Federal Government of Nigeria Budget for 2011. Abuja: 
Federal Ministry of Finance. [Online], Available: 
http://www.budgetoffice.gov.ng/2011_budget/proposal_2011/change/16.%20Summary_Health.pdf 
 
11. Mavimbe J. C., Braa J. & Bjune G. (2005). Assessing immunization data quality from routine reports in 
Mozambique. BMC Public Health, 108 (5): 632 - 639. [Online]. Available: 
www.pubmedcentral.nih.gov/articlerender.fcgi?artid=pmc1266378 [Downloaded 21/March/2009]. 
 
 
 
 
 
48 | P a g e  
 
12. Jack Eldon and Carol Bradford (2009): PRRINN-MNCH Report – Incorporating PRRINN Annual 
Review and MNCH Inception Review Narrative Report. 
 
13. Carol Bradford and Maisha Strozier (2010): PRRINN-MNCH Report – PRRINN-MNCH Annual Review: 
Executive Narrative Report. London: DFID Health Resource Center 
 
14. Obute Joseph and Anne McArthur (2010): Executive Summary - Rapid immunization assessment 
(Jigawa, Katsina, Yobe and Zamfara). London: DFID Health Resource Center. 
 
15. Jigawa State Malaria Control Booster Project (2011). Report of the listing of primary health facilities, 
communities/kindred, patent medicine vendors and community laboratories in Jigawa State. Jigawa: SMOH 
 
16. Ryman T. K., Dietz V. & Cairns K. L. (2008). Too little but not too late: Results of a literature review to 
improve routine immunization programs in developing countries. BMC Public Health, 134 (8) doi: 
10.1186/1472-6963-8-134. [PMC free article] [PubMed]. [Online]. Available: 
www.biomedcentral.com/1472-6963/8/134 [Downloaded 01/May/2009].   
 
17. World Health Organization, United Nations Children’s Fund. (1991). The state of the world’s children. 
Geneva: UNICEF: p. 14. 
 
18. UNICEF (2010). “Progress for Children – Achieving the MDGs with Equity. New York. 
 
19. Zwanenberg T. D. V. & Hull C. (1988). Improving immunisation: coverage in a province in Papua New 
Guinea. British Medical Journal, 296:1654 – 1656. 
 
20. Embree J. (2002). Assessing Immunization Programs. Can J Infect Dis, 13(4):224 – 225. 
 
21. National Primary Health Care Development Agency (2011). National Immunization Coverage Survey, 
2010. Abuja, Nigeria: NPHCDA. 
 
22. Banerjee A. V., Duflo E., Jameel A. L., Glennerster R.& Kothari, Dhruva (). Improving immunisation 
coverage in rural India: clustered randomised controlled evaluation of immunisation campaigns with and 
without incentives. BMJ(Online first) pg 1 to 9. 
 
23. Lim S.S., Stein D.B., Charrow A. & Murray C. J.L. (2008). Tracking progress towards universal 
 
 
 
 
49 | P a g e  
 
childhood immunisation and the impact of global initiatives: a systematic analysis of three-dose diphtheria, 
tetanus, and pertussis immunisation coverage. Lancet, 372: 2031-2046. 
 
24. Lu C., Michaud C. M., Gakidou E., Khan K. & Murray C. J. L. (2006). Effect of the Global Alliance for 
Vaccines and immunization on diphtheria, tetanus and pertussis vaccine coverage: an independent 
assessment. Lancet, 368: 1088-1092.  
 
25. Oruamabo R. S. & Okoji G. O. (1987). Immunisation status of children in Port Harcourt before and after 
commencing the Expanded Programme on Immunisation. Public Health 1987, 101(6): 447-452   
 
26. Health Partners International: Peer Participatory Rapid Health Appraisal for Action.  [Online], 
Available: www.healthpartners.int.co.uk  
 
27. National Programme on Immunization (2003). National Immunization Coverage Survey, 2003. Abuja, 
Nigeria: NPI 
 
28. Babalola S. (2007). Household Baseline Survey on the Factors Affecting Routine Immunization in 
Northern Nigeria, July/August 2007: Report of Pertinent Findings. Report Submitted to the Programme on 
Reviving Routine Immunization in northern Nigeria (PRRINN). Abuja: PATHS  
 
29. Babalola S & Adewuyi A. (2005): Factors Influencing Immunization Uptake in Nigeria: A Theory-based 
Research in Six States. Abuja: PATHS  
 
30. Center for Disease Control and Prevention (CDC). (2009). Measuring what matters to Virginians: 
Virginia performs (health and family). Atlanta: CDC. [Online], Available www.cdc.gov/vaccines/stats-
surv/imz-coverage.htm#nis] 
 
31. Partnership for Reviving Routine Immunization in Northern Nigeria; Maternal Newborn and Child 
Health Initiative (PRRINN-MNCH): 2009 Annual Report 
 
32. Partnership for Reviving Routine Immunization in Northern Nigeria; Maternal Newborn and Child 
Health Initiative (PRRINN-MNCH): 2008 Annual Report 
 
33. Partnership for Reviving Routine Immunization in Northern Nigeria; Maternal Newborn and Child 
Health Initiative (PRRINN-MNCH): 2010 Annual Report 
 
 
 
 
50 | P a g e  
 
 
 
34. Haddon B.,  Adogboba K.,Sokpo E., Aliakpajiak S., Anyebe W., Mckenzie A., & HughesC. (2009). 
PPRHAA Hospital Manual – PRRINN-MNCH Programme , Nigeria 
 
35. Beaglehole R., Bonita R., & Kjellström T. (1993). Basic Epidemiology. Geneva: World Health 
Organization: 39 – 62. 
 
36. Shefer A., Briss P., Rodewald L, Bernier R., Strikas R., Yusuf H., Ndiaye S., Williams S., Pappaioanou, 
M. & Hinmana R. (1999). Improving Immunization Coverage Rates: An Evidence Based Review of the 
Literature. Epidemiology Reviews 1999; 21(1):96-142 
 
37. Brownson R. C., Baker E. A., Leet, T. L. & Gillespie K. N. (2003). Evidence-Based Public Health. US: 
Oxford University Press: 3 – 23. 
 
38. Baum, F. (1995). Researching Public Health: behind the Qualitative-Quantitative Methodological 
Debate. Soc. Sci. Med. 40(4): 459 – 468 
 
39. National Statistical Service: Sample Size Calculator. [Online], Available 
http://www.nss.gov.au/nss/home.nsf/pages/Sample+size+calculator?OpenDocument 
 
40. Partnership for Reviving Routine Immunization in Northern Nigeria; Maternal Newborn and Child 
Health Initiative (PRRINN-MNCH): 2009 Annual Peer, Participatory Rapid Health Appraisal for Action 
(PPRHAA)in Jigawa State. 
 
41. Revised Logical Frame Work for Strengthening Routine Immunization in Jigawa State. 
 
41. National Population Commission (NPC) [Nigeria] and ICF MAcro (2009). Nigeria Demographic and 
Health Survey 2008.Abuja, Nigeria: National Population Commission and ICF Macro. 
 
  
 
 
 
 
 
51 | P a g e  
 
Appendices  
 
 
 
 
52 | P a g e  
 
Appendix 1 
 
 
 
 
Appendix 2   
Form G.1: Infant Immunization Cluster Form   State:-   L.G.A:- 
 
(1) Cluster number: (5) Name of the child Total 
(2) Date:          
 
 
Card 
 
 
Card 
plus 
history 
(3) Community: 
(4) Range of birth dates: 
From…………………………………… 
Until……………………………………. 
Child number in the cluster 1 2 3 4 5 6 7 8   
(6) Birth date           
(7) Sex (M,F)            
(8) Immunization  
       Card 
Yes/No           
(9) BCG Date/+/0           
Scar: Yes/No           
Source            
(10) DPT 1 
 
Date/+/0           
Source            
DPT2 Date/+/0           
Source            
DPT 3 Date/+/0           
Source            
(11) 
 
OPV 0 Date/+/0           
Source           
OPV 1 Date/+/0           
Source            
OPV 2 Date/+/0           
Source            
OPV 3 Date/+/0           
Source            
(12) HBV 1 Date/+/0           
Source            
HBV 2 Date/+/0           
Source            
HBV 3 Date/+/0           
Source            
(13)  Yellow Fever 
 
Date/+/0           
Source            
(14)  Measles  Date/+/0           
Source            
(15) Immunization  
        Status 
Not Imm.           
Partially            
Fully            
(16) Fully Immunized 
before 1 year of age  
Yes/No           
 
(17) Tally of households visited__________________________________ 
 
(18) Names of Interviewers 1_______________2_________________ Signature: Interviewers 1…………… 2…………… 
 
(19) Name of Field Supervisor_____________                                       Signature ……………….. 
 
 
Key: 
Date/+/0: 
Date = Copy date of immunization from card, if available 
+      = Mother reports immunization was given 
0      = Immunization not given 
 
 
 
 
 
 
Source of immunization 
OUT = Outreach 
HOS = Hospital 
HC = Health centre 
PRIV = Private 
NGO = Non-governmental organization 
SIA = Supplementary immunization activity 
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Appendix 3 
Form G.3: Tetanus Toxoid Immunization Cluster Form                 State:-     LGA:- 
 
(1) Cluster number: (5) Name of the mother  
 
 
Totals (to be 
completed by 
supervisor) 
(2) Date:         
(3) Community: 
(4) Range of birth dates: 
From…………………………………… 
Until……………………………………. 
Woman’s number in the cluster 1 2 3 4 5 6 7 8  
(6) Birth date of child          
(7) Total number of lifetime pregnancies          
 
 
 
 
 
 
 
 
 
(8) History of TT 
Immunization in last 
Pregnancy 
 
a) Number of TT doses 
received prior to last 
pregnancy 
 
        Dose LAST Pregnancy 
 
TTO=     TT1 = 
TT2 =     TT3 = 
TT4 =     TT5 or more= 
b) Number of TT doses 
received in last 
pregnancy 
 
        
c) Card available for TT 
received in last 
pregnancy? Y/N 
 
        Yes 
= 
No = 
d) Whether or not Card 
is available: was a card 
ever received?  
Y/N 
 
        Yes 
= 
No = 
         
C
ar
d
 
C
ar
d
+
H
is
t 
T
al
ly
 
so
u
rc
e 
 
 
 
 
 
(9) 
TT1 Date/Y/N           OUT= 
Source            HOS= 
TT2 Date/Y/N           HC= 
Source            PRIV= 
TT3 Date/Y/N           WCV= 
 Source            OTH= 
TT4 Date/Y/N           NGO= 
 Source             
TT5 Date/Y/N            
Source             
(10) Antenatal 
care 
Number of visits in Last pregnancy          One visit = 
Two or more visits= 
(11) Other 
visits to Health 
facility 
Number of visits in Last pregnancy          One visit = 
Two or more visits= 
 
 
 
 
(12) Delivery of baby 
W
h
er
e 
Home          Home = 
Hospital/HC          Hospital/HC= 
Other           Other = 
B
y
 w
h
o
 
Health staff           Health staff=  
TBA          TBA= 
Other          Other= 
Nobody          Nobody= 
 
(13) Woman protected 
against tetanus  
Yes by card (Y)          Yes by card (Y) 
Yes by card + history           Yes by card + history  
Not protected          
 
(14) Tally of households visited__________________________________ 
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(15) Names of Interviewers 1_______________           2_________________                                      Signature: Interviewers 1……………           2……………  
 
(16) Name of Field Supervisor_____________                                       Signature ……………….. 
 
 
 
 
 
Note: Data related to last pregnancy refers to pregnancy that led to a child now aged 0-11months 
 
Key:  
Date/+/0: 
Date = Copy date of immunization from card, if available 
+ (Y)     = Woman reports immunization was given 
0  (N)     = Immunization not given 
 
 
 
 
Source of immunization 
OUT = Outreach 
HOS = Hospital 
HC = Health centre 
PRIV = Private 
WCV = Well-child-visit 
OTH = others e.g. TT received due to injury 
NGO = Non-governmental organization 
SIA = Supplementary immunization activity 
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Appendix 4a: 
INFORMATION SHEET  
 
Dear Participant, 
 
Thank you for your acceptance to hear about this research study. This research study is being 
conducted for a mini-thesis which is a requirement for the Masters in Public Health degree at 
the University of the Western Cape, South Africa. 
 
I am a researcher from the School of Public Health, University of the Western Cape, South 
Africa. I am executing a research study on the status of routine immunization in Jigawa State. 
What I want to find out is information on routine immunization.  You were chosen as a 
respondent for this interview because you are a stakeholder in the primary health care 
systems in Jigawa State. 
 
The title of the research: Evaluation of the effectiveness of the Partnership for Reviving 
Routine Immunization in Northern Nigeria Programme in Jigawa State, Nigeria. 
 
The purpose of the study: The aim of the proposed study is to evaluate the performance of 
the PRRINN programme in improving routine immunization coverage in Jigawa State. After 
five years of programme implementation, it will be essential to have an independent 
assessment of the effectiveness of PRRINN and assess how well the primary objectives of the 
programme are being met. 
 
You will be asked to respond to some questions on routine immunization activities in Jigawa 
State. The questions will cut across your knowledge of routine immunization activities from 
2006 till date and the involvement of PRRINN. Questions on challenges of immunization will 
also be asked and your recommendations on certain immunization issues.  
 UNIVERSITY OF THE WESTERN CAPE 
Private Bag X 17, Bellville 7535, South Africa 
Tel: +27 21-959 3520, Fax: 27 21-959 2872 
E-mail:  
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Confidentiality: I will do my best to keep your personal information confidential. To help 
protect your confidentiality, the records of your participation shall be kept locked away and 
will be destroyed at the end of the research study. You will be asked to sign a consent form 
should you agree to participate in this research study. 
 
There are no known risks that may result from your participating in this survey. We also 
understand your time is valuable to you, so we do not intend to take your time more than 
necessary.  
 
This survey is not designed to help you personally, but the information and data we gather 
will help us understand the performance of the routine immunization in the State. This will 
help the government to better plan and implement their immunization intervention 
programmes. 
 
Your participation in this research is completely voluntary. You may choose not to take part 
at all. If you decide to participate in this research, you may stop participating at any time. If 
you decide not to participate in this study or if you stop participating at any time, you will not 
be penalized or lose any benefits to which you otherwise qualify. 
 
This research is being conducted by Adedayo Adegbenga of School of Public Health at the 
University of the Western Cape.  If you have any questions about the research study itself, 
please contact:  
 
Adedayo Adegbenga 
Student Number: 2816271 
P.O. BOX 14811, Wuse GPO. 
2816271@uwc.ac.za 
omindav@yahoo.com 
 
This research has been approved by the University of the Western Cape’s Senate Research 
Committee and Ethics Committee (UWC SRCEC) and also the National Health Research 
Ethics Committee (NHREC) of Nigeria. If you have any questions regarding your rights as a 
research participant or have concern that your rights have been violated in the course of your 
participation in this study, or if you wish to report any problems you have experienced related 
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to the study, please contact the UWC SRCEC and NHREC using the following: 
 
Head of Department: Uta Lehman 
Dean of the Faculty of Community and Health Sciences:  
University of the Western Cape 
Private Bag X17 
Bellville 7535  
+27-21-959-2809        
 
And 
 
National Health Research Ethics Committee (NHREC)  
Department of Health Planning, Research & Statistics 
Federal Ministry of Health, Abuja 
e-mail: chairman@nhrec.net, deskofficer@nhrec.net  
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Appendix 4b: 
UNIVERSITY OF THE WESTERN CAPE 
Private Bag X 17, Bellville 7535, South Africa 
     Tel: +27 21-959 3520, Fax: 27 21-959 
 
INFORMED CONSENT 
 
IRB Research Approval Number: 
 
Title of Research Project:  
Evaluation of the effectiveness of the Partnership for Reviving Routine Immunization in 
Northern Nigeria Programme in Jigawa State, Nigeria. 
 
This research study has been described to me in the language that I understand and I freely 
and voluntarily agree to participate. My questions about the study have been answered. I 
understand that my identity will not be disclosed and that I may chose not to participate in the 
study without giving a reason and this will not negatively affect me in any way.  
 
My signature says that I am willing to participate in this study. 
Participant’s Name :………………………………………………………………………….. 
Participant’s Signature :………………………………………………………………….. 
Consent Date : ………………………………………………………………………….. 
Researcher’s Name :………………………………………………………………………….. 
Researcher’s Signature :………………………………………………………………….. 
Date : ………………………………………………………………………….. 
Should you have any questions regarding this study or wish to report any problems you have 
experienced related to the study, please contact my Research Supervisor for this study: 
 
Research Supervisor’s Name:  Dr Ehimario Igumbor 
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University of the Western Cape 
Private Bag X17, Belville 7535 
Telephone: Office +27(021) 9593520 
Cell:  +27 82 920 0613 
Fax: (021)   959 2872                                            
Email: ehi.igumbor@gmail.com 
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Appendix 4c: Draft Facility Questionnaire (before field pre-testing) 
UNIVERSITY OF THE WESTERN CAPE 
SCHOOL OF PUBLIC HEALTH 
QUESTIONNAIRE TO ASSESS ROUTINE IMMUNIZATION SERVICES IN JIGAWA 
STATE 
NAME OF HEALTH FACILITY…………………………………… 
 LGA…………………...…..                  
DATE……………………………..         
INTERVIEWEE………………………………………………………  PHONE 
NO……………………………….                     
No OUT PATIENT DEPARTMENT / COLD CHAIN  
1 Name of Officer in 
charge………………………………………………………………………………… 
 
2 Do you have space for routine immunization services (OPD)?  YES/NO 
3 a) Do you have necessary equipment and furniture for routine immunization 
services?  
b) What type do you have? 
 
Cold chain  equipment          Electrical backup          Benches              Board or flip 
chart            
 
Teaching Aids    
 
Others (specific) 
………………………………………………………………………….. 
YES/NO 
 
4 a)Number of health workers in the health facility (especially the ones that carry out the RI 
services) ………………………………………………………………. 
b) List their cadre 
…………………………………………………………………………………………………
…………….. 
…………………………………………………………………………………………………
…………………………………….. 
…………………………………………………………………………………………………
…………………………………….. 
 
5 Do you keep records of RI services? 
…………………………………………………………………………………………………
……. 
 
If  yes, ask to see the Routine Immunization  register 
YES/NO 
6 Who do you report to? ……………………………………………………………………  
7 What is your reporting period?  Weekly………1 
Monthly……..2 
9 ROUTINE IMMUNIZATION RECORDS  
8 How many children were immunized in the last three months? …………. 
9 How many pregnant women were immunized against TT in the last three months?  
10 Which of these vaccines do you offer in the health facility? 
OPV 
DPT 
BCG 
TT 
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11 How many doses of the following antigens were given in the last three months in the health 
facility? 
OPV 
DPT 
BCG 
TT 
 
 
12 Has the attendance for RI services improved in the last two years? 
…………………………………………………………………………………………………
……………………………………….. 
…………………………………………………………………………………………………
………………………………………… 
…………………………………………………………………………………………………
………………………………………… 
 
 ROUTINE IMMUNIZATION CONSUMABLES (STOCK)  
13 What is the stock  out of BCG in the last 3 months (prior to the day of the assessment): 
 
 
14 What is the stock  of polio vaccine in the last 3 months (prior to the day of the assessment): 
 
 
15 What is the stock  out of hepatitis B in the last 3 months (prior to the day of the assessment): 
 
 
16 What is the stock  out of DPT in the last 3 months (prior to the day of the assessment):   
17 What is the stock  out of measles vaccine in the last 3 months (prior to the day of the 
assessment):  
 
18 What is the stock  out of yellow fever vaccine in the last 3 months (prior to the day of the 
assessment):  
 
19 What is the stock  out of TT in the last 3 months (prior to the day of the assessment):   
 TRAINING  
20 a) In the last two years how many times have you gone for training? 
 
 
b)List them 
…………………………………………………………………………………………………
…….. 
…………………………………………………………………………………………………
…….. 
…………………………………………………………………………………………………
…….. 
………………. 
21 Have you gone for training on the use of routine immunization services?. YES/NO 
 CHALLENGES AND RECOMMENDATIONS  
22 What are your challenges as it concerns routine immunization? 
…………………………………………………………………………………………………
…………………………………………. 
…………………………………………………………………………………………………
…………………………………………. 
…………………………………………………………………………………………………
…………………………………………. 
 
23 What are your recommendations for improving routine immunization in the State? 
…………………………………………………………………………………………………
…………………………………………. 
…………………………………………………………………………………………………
………………………………………… 
 
 
Researcher’s Name…………………            Signature…………     Phone No……………………. 
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Appendix 4d: Facility Questionnaire (after  field pre-testing) 
UNIVERSITY OF THE WESTERN CAPE 
SCHOOL OF PUBLIC HEALTH 
 
QUESTIONNAIRE TO ASSESS ROUTINE IMMUNIZATION SERVICES IN JIGAWA 
STATE 
 
NAME OF HEALTH FACILITY…………………………………… LGA…………………...…..
                  
DATE……………………………..         
 
INTERVIEWEE………………………………………………………  PHONE  
 
NO……………………………….                     
No OUT PATIENT DEPARTMENT / COLD CHAIN  
1 Name and Phone Number  of Officer in charge OR Officer in charge of RI in this facility: This is strictly for 
control just in case 
of clarification of 
information: Totally 
Optional. 
2 Who is the officer in charge of RI in this facility? 
 
 
2 Do you have space for routine immunization services (OPD)?  YES/NO 
3 a) Do you have necessary equipment and furniture for routine immunization 
services?  
b) What type do you have? 
 
Cold chain  equipment          Electrical backup          Benches              Board or flip 
chart            
 
Teaching Aids    
 
Others (specific) 
………………………………………………………………………….. 
YES/NO 
 
 Were the cold chain equipment in 2005 and 2006 adequate? 
 
Any extra comment? ………………………………………. 
YES/NO 
4 a)Number of health workers in the health facility (especially the ones that carry out the RI 
services) : 
 
b) List their cadre : 
 
 
 
5 Do you keep records of RI services?  
 
If  yes, ask to see the Routine Immunization  register 
YES/NO 
6 Who do you report to?  
 
 
7 What is your reporting period?  
 
 
 
 
Weekly………1 
Monthly……..2 
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9 ROUTINE IMMUNIZATION RECORDS  
8 How many children were immunized in this health facility in? 
 
 2005 2006 2011 
Number of children 
immunized? 
 
 
   
 
…………. 
9 
How many pregnant women were immunized against TT in the last three months? 
 
 2005 2006 2011 
Number of women 
immunized? 
 
 
   
 
 
10 Which of these vaccines do you offer in the health facility? 
OPV 
DPT 
BCG 
TT 
 
11 How many doses of the following antigens were given in this health facility? 
 
Antigen 2005 
(Annual) 
2006 (Annual) 2011 (Annual) 
BCG    
OPV1    
DPT1    
TT    
Yellow Fever    
    
 
 
 RI vaccinations given for the following antigens from the register?  
 
Antigen 2005 
(Annual) 
2006 (Annual) 2011 (Annual) 
BCG    
OPV1    
OPV3    
OPV3    
DPT1    
DPT2    
DPT3    
TT    
Yellow Fever    
    
 
 
12 Has the attendance for RI services improved in the last two years? 
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 ROUTINE IMMUNIZATION CONSUMABLES (STOCK)  
13 What is the stock  out of BCG in the last 3 months (prior to the day of the assessment): 
 
 
14 What is the stock  of polio vaccine in the last 3 months (prior to the day of the assessment): 
 
 
15 What is the stock  out of hepatitis B in the last 3 months (prior to the day of the assessment): 
 
 
16 What is the stock  out of DPT in the last 3 months (prior to the day of the assessment):   
17 What is the stock  out of measles vaccine in the last 3 months (prior to the day of the 
assessment):  
 
18 What is the stock  out of yellow fever vaccine in the last 3 months (prior to the day of the 
assessment):  
 
19 What is the stock  out of TT in the last 3 months (prior to the day of the assessment):   
 TRAINING  
20 a) In the last two years how many times have you gone for training? 
 
 
b)List them 
 
 
 
 
 
 
………………. 
21 Have you gone for training on the use of routine immunization services?. 
 
YES/NO 
 CHALLENGES AND RECOMMENDATIONS  
22 What are your challenges as it concerns routine immunization?  
 
 
 
 
 
 
 
23 What are your recommendations for improving routine immunization in the State? 
 
 
 
 
 
 
 
 
 
Researcher’s Name…………………             
 
Signature…………      
 
Phone No……………………. 
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Appendix 5:  
UNIVERSITY OF THE WESTERN CAPE 
SCHOOL OF PUBLIC HEALTH 
 
KEY INFORMANTS’ INTERVIEW GUIDE 
 
1. Introduction of study and administration of Consent form 
2. Name, Organization and Designation of Interviewee 
3. How do you rate routine immunization services in the State 
4. What can you say about the PRRINN programme in the State 
5. What can you say are the challenges facing routine immunization before 2006 
6. Has the challenges been addressed now 
7. What are the current challenges of routine immunization in the State 
8. What are your recommendations 
9. Any other information that you may want to share on routine immunization in the 
State 
N.B: some pertinent questions were asked depending on the interviewee’s organization. 
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Appendix 6a: UWC Senate Research and Ethics Committee approval 
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Appendix 6b: National Health Research Ethics committee of Nigeria (NHREC) approval 
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